| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B FKBP15 CTTNBP2 STRBP STXBP5 DLGAP5 EPB41L5 DCX CRMP1 MISP MRTFB DST ALMS1 CLMN STARD9 MYO3B MACF1 TLN2 KIF2A RP1 LIMCH1 MAP4K4 CNGA3 EP300 MYO16 | 3.54e-06 | 1099 | 164 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule binding | KIF21B STRBP DLGAP5 DCX DST ALMS1 STARD9 MACF1 KIF2A RP1 MAP4K4 | 4.99e-05 | 308 | 164 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.31e-05 | 167 | 164 | 8 | GO:0031490 | |
| GeneOntologyMolecularFunction | chromatin binding | URI1 ATRX LEMD3 REST CLOCK ZNF692 MEF2A JMJD1C PHC1 PHC2 SBNO1 PITX2 NCOA1 ANKRD17 MBD5 EP300 | 3.98e-04 | 739 | 164 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.58e-04 | 78 | 164 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.25e-04 | 229 | 164 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.39e-04 | 127 | 164 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | methylated histone binding | 7.16e-04 | 86 | 164 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 7.95e-04 | 88 | 164 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 8.12e-04 | 51 | 164 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | tubulin binding | KIF21B STRBP DLGAP5 DCX DST ALMS1 STARD9 MACF1 KIF2A RP1 MAP4K4 | 8.44e-04 | 428 | 164 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.08e-03 | 55 | 164 | 4 | GO:0061733 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ING3 ATRX DLGAP5 SRPK1 REST HUWE1 CLOCK JMJD1C PHC1 ZNF518A HMG20A RLF BPTF ARID2 TET1 EPC1 CENPI NCOA1 PRMT9 BICRAL KDM7A EP300 TBP | 5.43e-06 | 999 | 166 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | ING3 ATRX SRPK1 REST HUWE1 CLOCK JMJD1C PHC1 ZNF518A HMG20A RLF BPTF ARID2 TET1 EPC1 CENPI NCOA1 PRMT9 BICRAL KDM7A EP300 | 1.11e-05 | 896 | 166 | 21 | GO:0006325 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 TRIO STXBP5 MBP HLA-H DGKG PLXND1 REST DCX MEF2A CRMP1 SEMA3A FBXO38 MRTFB DST CSF1R ALMS1 CLMN MYO3B TET1 MACF1 RORB RP1 MAP4K4 CNGA3 EP300 FOXG1 MYO16 | 1.56e-05 | 1463 | 166 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | STRN3 SUPT20H ING3 ATRX ITGB1BP1 NACA REST CLOCK MEF2A RLF BPTF USF3 MRTFB UBP1 ARID2 TET1 EPC1 PITX2 NFYA MED12L NCOA1 RORB MGA EP300 TBP ZNF292 PYGO1 | 1.74e-05 | 1390 | 166 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 2.68e-05 | 44 | 166 | 5 | GO:1905168 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | ING3 ATRX REST HUWE1 CLOCK JMJD1C PHC1 RLF BPTF ARID2 TET1 EPC1 CENPI NCOA1 PRMT9 BICRAL KDM7A EP300 | 3.08e-05 | 741 | 166 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 TRIO STXBP5 MBP HLA-H DGKG PLXND1 REST DCX MEF2A CRMP1 SEMA3A FBXO38 MRTFB DST CSF1R ALMS1 CLMN MYO3B TET1 MACF1 MAP4K4 EP300 FOXG1 MYO16 | 3.62e-05 | 1285 | 166 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 5.62e-05 | 83 | 166 | 6 | GO:0010569 | |
| GeneOntologyBiologicalProcess | chromosome segregation | WAPL DLGAP5 SRPK1 CEP192 TEX14 SPICE1 MISP STARD9 ARID2 CENPI SPATA22 KIF2A PUM1 | 1.04e-04 | 465 | 166 | 13 | GO:0007059 |
| GeneOntologyBiologicalProcess | synaptic target recognition | 1.92e-04 | 3 | 166 | 2 | GO:0008039 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 2.23e-04 | 254 | 166 | 9 | GO:0000819 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 2.41e-04 | 108 | 166 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | regulation of focal adhesion assembly | 2.52e-04 | 70 | 166 | 5 | GO:0051893 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction assembly | 2.52e-04 | 70 | 166 | 5 | GO:0090109 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell differentiation | 2.88e-04 | 72 | 166 | 5 | GO:0001754 | |
| GeneOntologyBiologicalProcess | retinal rod cell development | 3.20e-04 | 17 | 166 | 3 | GO:0046548 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 3.28e-04 | 212 | 166 | 8 | GO:0000070 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 3.39e-04 | 115 | 166 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 3.48e-04 | 75 | 166 | 5 | GO:0150116 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 TRIO STXBP5 MBP PLXND1 REST DCX MEF2A SEMA3A DST CSF1R MYO3B TET1 MACF1 EP300 FOXG1 | 3.66e-04 | 748 | 166 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of binding | WAPL ZNF618 ITGB1BP1 SPPL3 EPB41L5 PLXND1 REST TEX14 BLM PITX2 EP300 | 3.76e-04 | 396 | 166 | 11 | GO:0051098 |
| GeneOntologyBiologicalProcess | retinal cone cell development | 3.82e-04 | 18 | 166 | 3 | GO:0046549 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 3.82e-04 | 4 | 166 | 2 | GO:0071596 | |
| GeneOntologyCellularComponent | chromatin | POU6F2 WAPL SUPT20H MAGED1 ING3 ATRX ZNF618 SRPK1 REST CLOCK MEF2A JMJD1C PHC1 PHC2 BPTF UBP1 ARID2 TET1 EPC1 PITX2 NFYA NCOA1 TMPO ANKRD17 RORB BICRAL MGA TCFL5 EP300 FOXG1 TBP | 5.05e-07 | 1480 | 165 | 31 | GO:0000785 |
| HumanPheno | Thin upper lip vermilion | ATRX TRIO TNRC6B HUWE1 WDR26 PHC1 EDEM3 BPTF ARID2 PITX2 MED12L ANKRD17 MBD5 EP300 FOXG1 UNC80 ZNF292 | 1.06e-07 | 339 | 58 | 17 | HP:0000219 |
| HumanPheno | Thin lips | ATRX TRIO TNRC6B HUWE1 WDR26 PHC1 EDEM3 BPTF ARID2 PITX2 MED12L ANKRD17 MBD5 EP300 FOXG1 UNC80 ZNF292 | 1.06e-07 | 339 | 58 | 17 | HP:0000213 |
| HumanPheno | Thin vermilion border | ATRX TRIO LEMD3 TNRC6B HUWE1 WDR26 PHC1 EDEM3 BPTF ARID2 PITX2 MED12L ANKRD17 MBD5 EP300 FOXG1 UNC80 ZNF292 | 6.95e-07 | 433 | 58 | 18 | HP:0000233 |
| HumanPheno | Motor stereotypy | TANC2 CACNA1B AFF2 ATRX TRIO ZMYM2 HUWE1 WDR26 ARID2 MACF1 MBD5 PUM1 EP300 FOXG1 | 1.89e-06 | 280 | 58 | 14 | HP:0000733 |
| HumanPheno | Abnormality of upper lip vermillion | ATRX TRIO TNRC6B HUWE1 WDR26 PHC1 EDEM3 BPTF CSF1R ARID2 PITX2 MED12L ANKRD17 MBD5 EP300 FOXG1 UNC80 ZNF292 | 1.93e-06 | 464 | 58 | 18 | HP:0011339 |
| HumanPheno | Autistic behavior | TANC2 CACNA1B FLG AFF2 ATRX TRIO ZMYM2 TNRC6B PLXND1 WDR26 DCX JMJD1C USF3 ALMS1 ARID2 MED12L ANKRD17 MBD5 EP300 FOXG1 ZNF292 | 7.93e-06 | 678 | 58 | 21 | HP:0000729 |
| HumanPheno | Abnormally increased volition | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 DCX JMJD1C BPTF CSF1R ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 9.84e-06 | 869 | 58 | 24 | HP:5200263 |
| HumanPheno | Disinhibition | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 JMJD1C BPTF CSF1R ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 9.87e-06 | 807 | 58 | 23 | HP:0000734 |
| HumanPheno | Inappropriate behavior | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 JMJD1C BPTF CSF1R ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 9.87e-06 | 807 | 58 | 23 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 JMJD1C BPTF CSF1R ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 9.87e-06 | 807 | 58 | 23 | HP:5200123 |
| HumanPheno | Social disinhibition | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 JMJD1C BPTF CSF1R ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 9.87e-06 | 807 | 58 | 23 | HP:5200029 |
| HumanPheno | Bulbous nose | TRIO ZMYM2 HUWE1 JMJD1C EDEM3 CSF1R MED12L MBD5 FOXG1 UNC80 ZNF292 | 1.23e-05 | 201 | 58 | 11 | HP:0000414 |
| HumanPheno | Recurrent maladaptive behavior | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO LEMD3 MAMLD1 ZMYM2 TNRC6B HUWE1 WDR26 DCX JMJD1C BPTF CSF1R ALMS1 ARID2 MED12L ANKRD17 MACF1 RORB MBD5 PUM1 EP300 FOXG1 UNC80 TBP ZNF292 | 1.38e-05 | 1293 | 58 | 30 | HP:5200241 |
| HumanPheno | Abnormal nasal tip morphology | ATRX TRIO ZMYM2 HUWE1 WDR26 JMJD1C EDEM3 BPTF CSF1R ARID2 MED12L MBD5 FOXG1 UNC80 ZNF292 | 1.72e-05 | 386 | 58 | 15 | HP:0000436 |
| HumanPheno | Reduced impulse control | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO LEMD3 ZMYM2 TNRC6B HUWE1 DCX JMJD1C BPTF CSF1R ALMS1 ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 1.86e-05 | 1032 | 58 | 26 | HP:5200045 |
| HumanPheno | Short philtrum | TRIO HUWE1 WDR26 JMJD1C EDEM3 BPTF ARID2 PITX2 MED12L ANKRD17 UNC80 ZNF292 | 2.00e-05 | 253 | 58 | 12 | HP:0000322 |
| HumanPheno | Abnormal thought pattern | TANC2 CACNA1B AFF2 ATRX TRIO ZMYM2 HUWE1 WDR26 ARID2 MACF1 MBD5 PUM1 EP300 FOXG1 TBP | 2.96e-05 | 404 | 58 | 15 | HP:5200269 |
| HumanPheno | Diagnostic behavioral phenotype | TANC2 CACNA1B FLG AFF2 ATRX TRIO ZMYM2 TNRC6B PLXND1 WDR26 DCX JMJD1C USF3 ALMS1 ARID2 MED12L ANKRD17 MBD5 EP300 FOXG1 ZNF292 | 3.62e-05 | 747 | 58 | 21 | HP:0025783 |
| HumanPheno | Restricted or repetitive behaviors or interests | TANC2 CACNA1B AFF2 ATRX TRIO ZMYM2 HUWE1 WDR26 ARID2 MACF1 MBD5 PUM1 EP300 FOXG1 | 4.45e-05 | 368 | 58 | 14 | HP:0031432 |
| HumanPheno | Perseverative thought | TANC2 CACNA1B AFF2 ATRX TRIO ZMYM2 HUWE1 WDR26 ARID2 MACF1 MBD5 PUM1 EP300 FOXG1 | 5.81e-05 | 377 | 58 | 14 | HP:0030223 |
| HumanPheno | Abnormal social development | TANC2 CACNA1B FLG ATP7B AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 JMJD1C BPTF CSF1R ARID2 MED12L ANKRD17 RORB MBD5 EP300 FOXG1 UNC80 TBP ZNF292 | 7.04e-05 | 908 | 58 | 23 | HP:0025732 |
| HumanPheno | Disordered formal thought process | TANC2 CACNA1B AFF2 ATRX TRIO ZMYM2 HUWE1 WDR26 ARID2 MACF1 MBD5 PUM1 EP300 FOXG1 | 7.53e-05 | 386 | 58 | 14 | HP:0025769 |
| HumanPheno | Hyperactivity | TANC2 CACNA1B FLG AFF2 ATRX TRIO ZMYM2 TNRC6B HUWE1 JMJD1C ARID2 MED12L ANKRD17 MBD5 EP300 FOXG1 ZNF292 | 9.85e-05 | 558 | 58 | 17 | HP:0000752 |
| HumanPheno | Abnormal esophagus physiology | CACNA1B ATP7B ATRX TRIO ZMYM2 NUP214 PLXND1 WDR26 DCX JMJD1C BLM EDEM3 DST CSF1R ALMS1 TPP1 ARID2 MED12L MACF1 MBD5 EP300 FOXG1 TBP | 1.09e-04 | 933 | 58 | 23 | HP:0025270 |
| HumanPheno | Delayed ability to sit | 3.00e-04 | 82 | 58 | 6 | HP:0025336 | |
| HumanPheno | Epicanthus | AFF2 ATRX TRIO ZMYM2 PLXND1 HUWE1 JMJD1C EDEM3 BPTF CSF1R ARID2 MACF1 PUM1 EP300 FOXG1 UNC80 ZNF292 | 3.20e-04 | 614 | 58 | 17 | HP:0000286 |
| HumanPheno | Abnormal esophagus morphology | CACNA1B ATP7B ATRX TRIO MAMLD1 ZMYM2 NUP214 PLXND1 WDR26 DCX JMJD1C BLM EDEM3 DST CSF1R ALMS1 TPP1 ARID2 MED12L MACF1 MBD5 EP300 FOXG1 TBP | 3.67e-04 | 1078 | 58 | 24 | HP:0002031 |
| MousePheno | abnormal cementum morphology | 2.23e-05 | 6 | 147 | 3 | MP:0003933 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 3.20e-05 | 18 | 147 | 4 | MP:0030485 | |
| Domain | Ago_hook | 2.26e-04 | 3 | 163 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 2.26e-04 | 3 | 163 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 2.26e-04 | 3 | 163 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 2.26e-04 | 3 | 163 | 2 | PF16608 | |
| Domain | DZF | 7.44e-04 | 5 | 163 | 2 | SM00572 | |
| Domain | LEM | 7.44e-04 | 5 | 163 | 2 | SM00540 | |
| Domain | Znf_FCS | 7.44e-04 | 5 | 163 | 2 | IPR012313 | |
| Domain | DZF_dom | 7.44e-04 | 5 | 163 | 2 | IPR006561 | |
| Domain | DZF | 7.44e-04 | 5 | 163 | 2 | PF07528 | |
| Domain | DZF | 7.44e-04 | 5 | 163 | 2 | PS51703 | |
| Domain | Spectrin | 1.02e-03 | 23 | 163 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.02e-03 | 23 | 163 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.02e-03 | 23 | 163 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.02e-03 | 23 | 163 | 3 | IPR001589 | |
| Domain | - | 1.11e-03 | 6 | 163 | 2 | 3.90.1290.10 | |
| Domain | Nuc_rcpt_coact | 1.11e-03 | 6 | 163 | 2 | IPR009110 | |
| Domain | DCX | 1.11e-03 | 6 | 163 | 2 | SM00537 | |
| Domain | ZF_FCS | 1.11e-03 | 6 | 163 | 2 | PS51024 | |
| Domain | GAR | 1.11e-03 | 6 | 163 | 2 | PS51460 | |
| Domain | GAS2 | 1.11e-03 | 6 | 163 | 2 | PF02187 | |
| Domain | - | 1.11e-03 | 6 | 163 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.11e-03 | 6 | 163 | 2 | IPR003108 | |
| Domain | GAS2 | 1.11e-03 | 6 | 163 | 2 | SM00243 | |
| Domain | ZF_PHD_2 | 1.47e-03 | 95 | 163 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.54e-03 | 96 | 163 | 5 | PS01359 | |
| Domain | LEM/LEM-like_dom | 1.54e-03 | 7 | 163 | 2 | IPR011015 | |
| Domain | LEM_dom | 1.54e-03 | 7 | 163 | 2 | IPR003887 | |
| Domain | - | 1.54e-03 | 7 | 163 | 2 | 3.10.20.230 | |
| Domain | Plectin | 1.54e-03 | 7 | 163 | 2 | PF00681 | |
| Domain | Znf_MYM | 1.54e-03 | 7 | 163 | 2 | IPR010507 | |
| Domain | LEM | 1.54e-03 | 7 | 163 | 2 | PF03020 | |
| Domain | ZnF_UBR1 | 1.54e-03 | 7 | 163 | 2 | SM00396 | |
| Domain | Plectin_repeat | 1.54e-03 | 7 | 163 | 2 | IPR001101 | |
| Domain | LEM | 1.54e-03 | 7 | 163 | 2 | PS50954 | |
| Domain | DCX | 1.54e-03 | 7 | 163 | 2 | PF03607 | |
| Domain | ZF_UBR | 1.54e-03 | 7 | 163 | 2 | PS51157 | |
| Domain | zf-UBR | 1.54e-03 | 7 | 163 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.54e-03 | 7 | 163 | 2 | IPR003126 | |
| Domain | zf-FCS | 1.54e-03 | 7 | 163 | 2 | PF06467 | |
| Domain | - | 1.54e-03 | 7 | 163 | 2 | 1.10.720.40 | |
| Domain | PLEC | 1.54e-03 | 7 | 163 | 2 | SM00250 | |
| Domain | Znf_FYVE_PHD | 1.85e-03 | 147 | 163 | 6 | IPR011011 | |
| Domain | Spectrin_repeat | 2.02e-03 | 29 | 163 | 3 | IPR002017 | |
| Domain | DC | 2.05e-03 | 8 | 163 | 2 | PS50309 | |
| Domain | Glyco_hydro_47 | 2.05e-03 | 8 | 163 | 2 | IPR001382 | |
| Domain | Doublecortin_dom | 2.05e-03 | 8 | 163 | 2 | IPR003533 | |
| Domain | UBA-like | 2.36e-03 | 64 | 163 | 4 | IPR009060 | |
| Domain | Zinc_finger_PHD-type_CS | 2.50e-03 | 65 | 163 | 4 | IPR019786 | |
| Domain | CH | 2.50e-03 | 65 | 163 | 4 | SM00033 | |
| Domain | SPEC | 2.69e-03 | 32 | 163 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.69e-03 | 32 | 163 | 3 | IPR018159 | |
| Domain | HLH | 2.90e-03 | 111 | 163 | 5 | PF00010 | |
| Domain | ARM-type_fold | 2.99e-03 | 339 | 163 | 9 | IPR016024 | |
| Domain | CH | 3.28e-03 | 70 | 163 | 4 | PF00307 | |
| Domain | - | 3.45e-03 | 71 | 163 | 4 | 1.10.418.10 | |
| Domain | HLH | 3.51e-03 | 116 | 163 | 5 | SM00353 | |
| Domain | BHLH | 3.64e-03 | 117 | 163 | 5 | PS50888 | |
| Domain | bHLH_dom | 3.77e-03 | 118 | 163 | 5 | IPR011598 | |
| Domain | CH | 3.81e-03 | 73 | 163 | 4 | PS50021 | |
| Domain | PHD | 4.20e-03 | 75 | 163 | 4 | PF00628 | |
| Domain | CH-domain | 4.20e-03 | 75 | 163 | 4 | IPR001715 | |
| Domain | EF_HAND_2 | 4.22e-03 | 231 | 163 | 7 | PS50222 | |
| Domain | EF_hand_dom | 4.32e-03 | 232 | 163 | 7 | IPR002048 | |
| Domain | EF_Hand_1_Ca_BS | 4.39e-03 | 175 | 163 | 6 | IPR018247 | |
| Domain | Znf_PHD-finger | 5.06e-03 | 79 | 163 | 4 | IPR019787 | |
| Domain | Kinesin_motor_CS | 5.46e-03 | 41 | 163 | 3 | IPR019821 | |
| Domain | - | 5.67e-03 | 244 | 163 | 7 | 3.30.70.330 | |
| Domain | - | 6.15e-03 | 449 | 163 | 10 | 3.30.40.10 | |
| Domain | SEA | 6.43e-03 | 14 | 163 | 2 | SM00200 | |
| Domain | EF-hand_7 | 6.55e-03 | 85 | 163 | 4 | PF13499 | |
| Domain | - | 6.65e-03 | 44 | 163 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 6.65e-03 | 44 | 163 | 3 | PF00225 | |
| Domain | KISc | 6.65e-03 | 44 | 163 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 6.65e-03 | 44 | 163 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 6.65e-03 | 44 | 163 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 6.65e-03 | 44 | 163 | 3 | PS50067 | |
| Domain | Znf_RING/FYVE/PHD | 7.14e-03 | 459 | 163 | 10 | IPR013083 | |
| Domain | Nucleotide-bd_a/b_plait | 7.62e-03 | 258 | 163 | 7 | IPR012677 | |
| Domain | PHD | 7.68e-03 | 89 | 163 | 4 | SM00249 | |
| Domain | UBA | 7.99e-03 | 47 | 163 | 3 | PS50030 | |
| Domain | Znf_PHD | 8.30e-03 | 91 | 163 | 4 | IPR001965 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.86e-05 | 42 | 111 | 5 | M41826 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 2.10e-05 | 43 | 111 | 5 | M41827 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.05e-05 | 25 | 111 | 4 | M27880 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.28e-04 | 13 | 111 | 3 | M46434 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.41e-04 | 34 | 111 | 4 | M46422 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.97e-04 | 37 | 111 | 4 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.97e-04 | 37 | 111 | 4 | M29790 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.67e-04 | 40 | 111 | 4 | MM15000 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.95e-04 | 272 | 111 | 9 | M29619 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 3.24e-04 | 42 | 111 | 4 | M41828 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 3.24e-04 | 42 | 111 | 4 | MM15677 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.88e-04 | 44 | 111 | 4 | MM15678 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.88e-04 | 44 | 111 | 4 | M27295 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 5.00e-04 | 47 | 111 | 4 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.87e-04 | 49 | 111 | 4 | M618 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 6.56e-04 | 22 | 111 | 3 | MM15656 | |
| Pubmed | TANC2 KIF21B FKBP15 STRN3 CTTNBP2 MAGED1 TRIO NHSL2 ZNF618 UBR4 DLGAP5 ZMYM2 TNRC6B HUWE1 WDR26 DCX YWHAB CRMP1 SPICE1 DST OTUD4 ANKRD17 MACF1 TLN2 ZFR KIF2A LIMCH1 MGA MAP4K4 UNC79 ARHGAP21 FOXG1 | 5.22e-18 | 963 | 167 | 32 | 28671696 | |
| Pubmed | FLG SUPT20H MAGED1 ING3 ATRX STRBP UBR4 NACA ZMYM2 TNRC6B NUP214 CEP192 MEF2A JMJD1C HMG20A BLM RLF BPTF DST ALMS1 ARID2 EPC1 TNRC6A NFYA MARF1 OTUD4 NCOA1 ANKRD17 ZFR PUM1 MGA EP300 TBP PYGO1 WDR48 | 1.38e-15 | 1429 | 167 | 35 | 35140242 | |
| Pubmed | ZFYVE16 ZGRF1 UBR4 ZMYM2 TNRC6B NUP214 HUWE1 ECPAS WDR26 JMJD1C PHC1 RLF MRTFB DST ALMS1 TET1 TNRC6A ANKRD17 MGA ARHGAP21 | 1.79e-14 | 418 | 167 | 20 | 34709266 | |
| Pubmed | KRT3 STRN3 TRIO ZFYVE16 NACA KPRP EPB41L5 TNRC6B ECPAS YWHAB CRMP1 BLM BPTF MISP DST ARID2 MACF1 TLN2 ARHGAP21 | 1.76e-12 | 472 | 167 | 19 | 38943005 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TRIO EXPH5 EPB41L5 CEP192 WDR26 YWHAB SPICE1 FAM83B FSIP2 DST ALMS1 CLMN STARD9 TET1 ANKRD17 MACF1 KIF2A LIMCH1 PATJ PUM1 MAP4K4 ARHGAP21 CNOT4 | 4.56e-12 | 861 | 167 | 24 | 36931259 |
| Pubmed | TANC2 FKBP15 STRN3 CTTNBP2 MAGED1 TNRC6B CEP192 ECPAS YWHAB SPICE1 FAM83B DST ALMS1 TNRC6A KIF2A PATJ PUM1 MAP4K4 | 6.71e-12 | 446 | 167 | 18 | 24255178 | |
| Pubmed | FKBP15 WAPL MAGED1 ATP7B TRIO ZFYVE16 LEMD3 NACA DLGAP5 EPB41L5 TNRC6B NUP214 HUWE1 JMJD1C EDEM3 ALMS1 CLMN TNRC6A PATJ PUM1 MGA MAP4K4 | 9.24e-12 | 733 | 167 | 22 | 34672954 | |
| Pubmed | SUPT20H EXPH5 ZMYM2 NUP214 YWHAB USF3 DST ARID2 TNRC6A NFYA ANKRD17 MACF1 BICRAL MBD5 MGA MAP4K4 EP300 PYGO1 | 2.75e-11 | 486 | 167 | 18 | 20936779 | |
| Pubmed | TANC2 WAPL SUPT20H ATP7B ING3 ZNF618 TNRC6B RALGAPA2 WDR26 ZNF518A HMG20A EDEM3 BPTF ALMS1 ARID2 EPC1 TNRC6A CRNN ANKRD17 MACF1 BICRAL MGA EP300 UNC80 TBP WDR48 | 2.88e-11 | 1116 | 167 | 26 | 31753913 | |
| Pubmed | STRN3 SUPT20H UBQLN1 MAGED1 ING3 ATRX LEMD3 NACA EPB41L5 ZMYM2 TNRC6B SRPK1 PHC2 HMG20A FAM83B BLM MRTFB DST UBP1 TPP1 ARID2 TNRC6A OTUD4 ANKRD17 MACF1 KIF2A LIMCH1 PATJ TBP | 1.47e-10 | 1497 | 167 | 29 | 31527615 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 CACNA1B MAGED1 ATRX TRIO STRBP ITGB1BP1 UBR4 TNRC6B NUP214 YWHAB CLMN UBP1 OTUD4 TLN2 ZFR LIMCH1 | 1.70e-10 | 475 | 167 | 17 | 31040226 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | STRN3 WAPL ATRX DLGAP5 ZMYM2 NUP214 REST HUWE1 TSSC4 ECPAS PHC2 SPICE1 BLM FBXO38 BPTF OTUD4 TMPO ANKRD17 TLN2 LIMCH1 MAP4K4 | 1.80e-10 | 774 | 167 | 21 | 15302935 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | WAPL ING3 STRBP UBR4 ZMYM2 HUWE1 ECPAS MEF2A JMJD1C BLM BPTF UBP1 EPC1 PITX2 NFYA ANKRD17 ZFR PUM1 MGA EP300 FOXG1 TBP | 1.82e-10 | 857 | 167 | 22 | 25609649 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B WAPL SUPT20H EXPH5 NUP214 ECPAS BLM ARID2 TMPO ZFR KIF2A RP1 LIMCH1 PUM1 MAP4K4 ARHGAP21 ZNF292 | 3.41e-10 | 497 | 167 | 17 | 36774506 |
| Pubmed | MAGED1 ZFYVE16 LEMD3 EXPH5 EPB41L5 TNRC6B JMJD1C FAM83B ALMS1 TNRC6A MACF1 MAP4K4 ARHGAP21 | 5.46e-10 | 263 | 167 | 13 | 34702444 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | WAPL ATRX DLGAP5 ZMYM2 JMJD1C PHC1 HMG20A BLM RLF FSIP2 FBXO38 BPTF SBNO1 ARID2 TMPO MGA ZNF292 | 6.99e-09 | 608 | 167 | 17 | 36089195 |
| Pubmed | Interaction network of human early embryonic transcription factors. | KPRP ZMYM2 NUP214 RLF BPTF ALMS1 ARID2 TET1 EPC1 PITX2 NCOA1 MGA EP300 | 1.75e-08 | 351 | 167 | 13 | 38297188 |
| Pubmed | WAPL MAGED1 ATRX STRBP NACA SRPK1 JMJD1C DST TPP1 MARF1 ANKRD17 KIF2A PATJ MAP4K4 ARHGAP21 CNOT4 WDR48 | 1.86e-08 | 650 | 167 | 17 | 38777146 | |
| Pubmed | TANC2 CTTNBP2 ZNF618 EXPH5 EPB41L5 RALGAPA2 JMJD1C USF3 ALMS1 ARID2 UBR3 MACF1 MBD5 MGA UNC80 | 1.86e-08 | 493 | 167 | 15 | 15368895 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FKBP15 STRN3 WAPL ATRX ZFYVE16 NACA DLGAP5 ZMYM2 TNRC6B NUP214 MRTFB DST ALMS1 CLMN ARID2 TMPO ANKRD17 MACF1 ZFR ARHGAP21 | 2.71e-08 | 934 | 167 | 20 | 33916271 |
| Pubmed | FLG WAPL ING3 STRBP NACA KPRP NUP214 MUC13 ECPAS YWHAB CRMP1 MISP ZFR LIMCH1 PUM1 MGA ARHGAP21 EP300 | 2.78e-08 | 754 | 167 | 18 | 35906200 | |
| Pubmed | MAGED1 LEMD3 NACA TNRC6B NUP214 JMJD1C ALMS1 SBNO1 EPC1 TNRC6A ANKRD17 | 2.87e-08 | 242 | 167 | 11 | 34011540 | |
| Pubmed | UBQLN1 ATRX ZFYVE16 LEMD3 EXPH5 UBR4 ZMYM2 HUWE1 ZNF518A HMG20A RLF MRTFB DST MACF1 PUM1 MGA | 3.10e-08 | 591 | 167 | 16 | 15231748 | |
| Pubmed | AFF2 CCDC30 LEMD3 EPB41L5 MUC16 TNRC6B CEP192 PLXND1 HUWE1 FAM83B BLM PPP2R3A DST TNRC6A TMPO ZFR MGA ARHGAP21 | 4.37e-08 | 777 | 167 | 18 | 35844135 | |
| Pubmed | 5.70e-08 | 152 | 167 | 9 | 38360978 | ||
| Pubmed | WAPL SUPT20H UBQLN1 MAGED1 ATRX TRIO UBR4 ZMYM2 HUWE1 WDR26 YWHAB CRMP1 HMG20A DST SBNO1 TPP1 MACF1 TLN2 RORB MAP4K4 ARHGAP21 EP300 ZNF292 | 6.08e-08 | 1285 | 167 | 23 | 35914814 | |
| Pubmed | WAPL TNRC6B HUWE1 JMJD1C BPTF MRTFB ALMS1 ARID2 TET1 TMPO ZFR PATJ MGA MAP4K4 EP300 | 7.57e-08 | 549 | 167 | 15 | 38280479 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SUPT20H ING3 JMJD1C ZNF518A UBP1 ARID2 EPC1 NCOA1 TMPO BICRAL MGA EP300 ZNF292 | 7.58e-08 | 398 | 167 | 13 | 35016035 |
| Pubmed | TRIO TNRC6B CEP192 HELB MISP DST ALMS1 TNRC6A MACF1 ARHGAP21 | 7.71e-08 | 209 | 167 | 10 | 36779422 | |
| Pubmed | URI1 ING3 ZMYM2 REST CLOCK MEF2A PHC1 HMG20A BPTF UBP1 ARID2 PITX2 NFYA NCOA1 ZFR MGA TBP ZNF292 | 7.85e-08 | 808 | 167 | 18 | 20412781 | |
| Pubmed | LEMD3 STRBP UBR4 REST BPTF SBNO1 UBP1 TET1 MACF1 KDM7A PUM1 ZNF292 | 9.06e-08 | 335 | 167 | 12 | 15741177 | |
| Pubmed | FKBP15 ZFYVE16 STXBP5 TNRC6B NUP214 CEP192 STARD9 OTUD4 MACF1 LIMCH1 PUM1 ARHGAP21 WDR48 | 9.81e-08 | 407 | 167 | 13 | 12693553 | |
| Pubmed | KIF21B SUPT20H ING3 ATRX FPGS UBR4 ADCK2 NUP214 REST CRMP1 RLF SBNO1 UBP1 ARID2 EPC1 CENPI NCOA1 ANKRD17 MGA MAP4K4 EP300 ZNF292 WDR48 | 1.08e-07 | 1327 | 167 | 23 | 32694731 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.28e-07 | 167 | 167 | 9 | 20362541 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SUPT20H MAGED1 ATRX ZGRF1 ZMYM2 CEP192 HUWE1 FAM83B BLM MRTFB ALMS1 ARID2 TNRC6A MACF1 PATJ | 1.83e-07 | 588 | 167 | 15 | 38580884 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | UBQLN1 MAGED1 ING3 AFF2 UBR4 NUP214 TEX14 USF3 MRTFB ARID2 ZFR PATJ MGA | 1.84e-07 | 430 | 167 | 13 | 35044719 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POU6F2 URI1 ATRX TRIO ST7 MBP TNRC6B CEP192 HUWE1 ECPAS MEF2A JMJD1C RLF BPTF PPP2R3A USF3 MRTFB CLMN ANKRD17 MACF1 LIMCH1 PATJ MBD5 EP300 | 2.10e-07 | 1489 | 167 | 24 | 28611215 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SUPT20H ING3 ATRX LEMD3 DLGAP5 ZMYM2 NUP214 REST CLOCK JMJD1C PHC2 HMG20A BLM BPTF MISP DST UBP1 EPC1 TMPO ZFR MGA EP300 | 2.91e-07 | 1294 | 167 | 22 | 30804502 |
| Pubmed | KIF21B WAPL NACA DLGAP5 PLXND1 ECPAS CLOCK DST TET1 TNRC6A MED12L ANKRD17 KDM7A MAP4K4 | 3.08e-07 | 529 | 167 | 14 | 14621295 | |
| Pubmed | The Celsr3-Kif2a axis directs neuronal migration in the postnatal brain. | 4.33e-07 | 4 | 167 | 3 | 34582949 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAGED1 STRBP KPRP EPB41L5 TNRC6B RBMS3 TNRC6A MARF1 OTUD4 ANKRD17 MACF1 ZFR PUM1 MGA ZNF292 WDR48 | 4.78e-07 | 724 | 167 | 16 | 36232890 |
| Pubmed | 4.94e-07 | 14 | 167 | 4 | 36213234 | ||
| Pubmed | SUPT20H ZFYVE16 LEMD3 DLGAP5 TNRC6B HUWE1 YWHAB PHC1 PHC2 SPICE1 RLF DST ALMS1 EPC1 EP300 | 5.88e-07 | 645 | 167 | 15 | 25281560 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.65e-07 | 203 | 167 | 9 | 22083510 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | WAPL ATRX UBR4 ZMYM2 NUP214 HUWE1 FBXO38 BPTF ARID2 TMPO KIF2A | 6.83e-07 | 332 | 167 | 11 | 32786267 |
| Pubmed | 7.45e-07 | 104 | 167 | 7 | 9205841 | ||
| Pubmed | ARMT1 URI1 TRIO ZFYVE16 LEMD3 ST7 CEP192 HUWE1 YWHAB SPICE1 BLM FBXO38 PPP2R3A TNRC6A OTUD4 TMPO UBR3 PUM1 WDR48 | 7.90e-07 | 1049 | 167 | 19 | 27880917 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | STRN3 TRIO ST7 STXBP5 FPGS TNRC6B CEP192 ECPAS FAM83B PPP2R3A MRTFB ALMS1 TNRC6A MGA MAP4K4 ARHGAP21 CNOT4 | 8.60e-07 | 853 | 167 | 17 | 28718761 |
| Pubmed | 8.73e-07 | 272 | 167 | 10 | 31010829 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WAPL ATRX LEMD3 STRBP DLGAP5 ZMYM2 NUP214 JMJD1C HMG20A BLM BPTF ARID2 MARF1 TMPO ZFR SPATA22 PUM1 MGA | 8.81e-07 | 954 | 167 | 18 | 36373674 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 9.54e-07 | 212 | 167 | 9 | 33853758 | |
| Pubmed | 9.94e-07 | 157 | 167 | 8 | 30186101 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 26763578 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG FKBP15 SUPT20H ZNF618 ZMYM2 TNRC6B DCX PHC2 CRMP1 HMG20A BLM BPTF DST ARID2 TMPO MACF1 KIF2A MAP4K4 ZNF292 | 1.25e-06 | 1082 | 167 | 19 | 38697112 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.25e-06 | 283 | 167 | 10 | 30585729 | |
| Pubmed | ARMT1 WAPL ATRX DLGAP5 CEP192 HUWE1 DCX CRMP1 CLMN UBP1 TET1 OTUD4 ANKRD17 MACF1 KIF2A PATJ PUM1 MGA ARHGAP21 | 1.28e-06 | 1084 | 167 | 19 | 11544199 | |
| Pubmed | 1.56e-06 | 225 | 167 | 9 | 12168954 | ||
| Pubmed | 1.58e-06 | 74 | 167 | 6 | 29795351 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | SUPT20H ZGRF1 KCP TNRC6B RALGAPA2 BPTF DST TMPO PUM1 MGA EP300 | 1.63e-06 | 363 | 167 | 11 | 14691545 |
| Pubmed | ZFYVE16 EPB41L5 TNRC6B NUP214 ECPAS JMJD1C SPICE1 FAM83B DST TMPO ANKRD17 MACF1 PATJ MAP4K4 ARHGAP21 | 1.86e-06 | 708 | 167 | 15 | 39231216 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.31e-06 | 123 | 167 | 7 | 26912792 | |
| Pubmed | 2.44e-06 | 177 | 167 | 8 | 26206133 | ||
| Pubmed | TANC2 ARMT1 STRBP UBR4 DLGAP5 ZMYM2 MUC16 ADCK2 UBP1 ARID2 OTUD4 NCOA1 ANKRD17 EP300 | 2.78e-06 | 638 | 167 | 14 | 31182584 | |
| Pubmed | 3.11e-06 | 83 | 167 | 6 | 28794006 | ||
| Pubmed | 3.25e-06 | 246 | 167 | 9 | 15345747 | ||
| Pubmed | 3.34e-06 | 130 | 167 | 7 | 12421765 | ||
| Pubmed | MAGED1 LEMD3 UBR4 NACA MUC16 HUWE1 ECPAS PHC1 PHC2 BPTF PPP2R3A | 3.75e-06 | 396 | 167 | 11 | 26687479 | |
| Pubmed | MEPE Localization in the Craniofacial Complex and Function in Tooth Dentin Formation. | 3.75e-06 | 7 | 167 | 3 | 26927967 | |
| Pubmed | MAGED1 KPRP EPB41L5 TNRC6B NUP214 SPICE1 FAM83B MISP TNRC6A TMPO ANKRD17 ZFR PUM1 CNOT4 | 3.76e-06 | 655 | 167 | 14 | 35819319 | |
| Pubmed | 3.95e-06 | 322 | 167 | 10 | 26514267 | ||
| Pubmed | ITGB1BP1 UBR4 ADCK2 SSTR2 ECPAS RALGAPA2 MBOAT2 FAM135B SPICE1 MGAT5 ST6GALNAC5 TMPO TLN2 | 4.06e-06 | 568 | 167 | 13 | 9110174 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.49e-06 | 256 | 167 | 9 | 33397691 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | ITGB1BP1 UBR4 ADCK2 SSTR2 ECPAS RALGAPA2 MBOAT2 FAM135B SPICE1 MGAT5 ST6GALNAC5 TMPO TLN2 | 4.55e-06 | 574 | 167 | 13 | 8619474 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ZMYM2 PHC1 PHC2 ZNF518A HELB RLF FBXO38 BPTF TET1 MBD5 MGA ZNF292 | 5.41e-06 | 495 | 167 | 12 | 27705803 |
| Pubmed | ARMT1 CTTNBP2 TRIO ITGB1BP1 JMJD1C DST ALMS1 CLMN MED12L MACF1 MGA ARHGAP21 | 5.64e-06 | 497 | 167 | 12 | 23414517 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 7.19e-06 | 146 | 167 | 7 | 23892456 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | WAPL UBR4 NACA DLGAP5 EPB41L5 SRPK1 NUP214 HUWE1 TSSC4 YWHAB BLM RLF DST TPP1 ANKRD17 MACF1 ZFR KIF2A PUM1 MGA | 8.56e-06 | 1353 | 167 | 20 | 29467282 |
| Pubmed | 9.35e-06 | 152 | 167 | 7 | 34299191 | ||
| Pubmed | 9.74e-06 | 101 | 167 | 6 | 10997877 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 9.74e-06 | 101 | 167 | 6 | 24613305 | |
| Pubmed | TANC2 CACNA1B FKBP15 STRN3 MAGED1 TRIO UBR4 NACA TNRC6B DGKG HUWE1 WDR26 TNRC6A UBR3 MACF1 TLN2 KIF2A MAP4K4 | 1.02e-05 | 1139 | 167 | 18 | 36417873 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | STRN3 WAPL LEMD3 NACA ZMYM2 NUP214 CEP192 TSSC4 SPICE1 FAM83B BLM FBXO38 EDEM3 MISP ARID2 TMPO TLN2 ZFR | 1.24e-05 | 1155 | 167 | 18 | 20360068 |
| Pubmed | 1.27e-05 | 10 | 167 | 3 | 15601870 | ||
| Pubmed | Osterix regulates tooth root formation in a site-specific manner. | 1.27e-05 | 10 | 167 | 3 | 25568170 | |
| Pubmed | 1.29e-05 | 222 | 167 | 8 | 37071664 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | LEMD3 MAMLD1 TNRC6B NUP214 JMJD1C TNRC6A TMPO ANKRD17 ZFR PUM1 EP300 | 1.44e-05 | 457 | 167 | 11 | 32344865 |
| Pubmed | 1.57e-05 | 65 | 167 | 5 | 22496869 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.72e-05 | 231 | 167 | 8 | 16452087 | |
| Pubmed | 1.74e-05 | 11 | 167 | 3 | 10454579 | ||
| Pubmed | STRBP UBR4 SRPK1 NUP214 HUWE1 ECPAS BLM BPTF DST ANKRD17 MACF1 ZFR PUM1 | 1.79e-05 | 653 | 167 | 13 | 22586326 | |
| Pubmed | MAGED1 ATRX NUP214 REST HUWE1 HMG20A HELB BPTF ALMS1 TNRC6A UNC79 | 1.83e-05 | 469 | 167 | 11 | 27634302 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.01e-05 | 171 | 167 | 7 | 20201926 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ZFYVE16 NUP214 YWHAB FAM83B MRTFB DST CLMN TMPO MACF1 LIMCH1 PATJ ARHGAP21 | 2.02e-05 | 565 | 167 | 12 | 25468996 |
| Pubmed | FLG KRT3 STRN3 ATRX NHSL2 STRBP UBR4 TEX14 YWHAB BPTF DST SBNO1 STARD9 MARF1 TMPO MACF1 ZFR LIMCH1 ARHGAP21 ZNF292 | 2.14e-05 | 1442 | 167 | 20 | 35575683 | |
| Pubmed | 2.15e-05 | 116 | 167 | 6 | 21282530 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.27e-05 | 394 | 167 | 10 | 27248496 | |
| Pubmed | Transgenic expression of Dspp partially rescued the long bone defects of Dmp1-null mice. | 2.29e-05 | 2 | 167 | 2 | 26686820 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 29791863 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 21705419 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 11002341 | ||
| Interaction | PHF21A interactions | ZFYVE16 ZGRF1 UBR4 ZMYM2 TNRC6B NUP214 HUWE1 ECPAS CLOCK WDR26 JMJD1C HMG20A RLF MRTFB DST ALMS1 TET1 TNRC6A MGA ARHGAP21 | 7.93e-12 | 343 | 166 | 20 | int:PHF21A |
| Interaction | CNOT9 interactions | STRN3 MAGED1 ST7 TNRC6B CEP192 JMJD1C ALMS1 TNRC6A MARF1 OTUD4 ANKRD17 PUM1 MGA MAP4K4 CNOT4 | 8.49e-10 | 231 | 166 | 15 | int:CNOT9 |
| Interaction | KDM1A interactions | ZFYVE16 ZGRF1 FPGS UBR4 ZMYM2 TNRC6B NUP214 HUWE1 ECPAS CLOCK WDR26 JMJD1C PHC1 PHC2 SPICE1 HMG20A RLF MRTFB DST ALMS1 TET1 TNRC6A ANKRD17 SPATA22 MGA ARHGAP21 EP300 FOXG1 | 3.31e-09 | 941 | 166 | 28 | int:KDM1A |
| Interaction | RCOR1 interactions | ZFYVE16 ZGRF1 UBR4 ZMYM2 TNRC6B REST HUWE1 ECPAS CLOCK WDR26 JMJD1C HMG20A RLF MRTFB DST ALMS1 TET1 ANKRD17 MGA ARHGAP21 | 4.83e-09 | 494 | 166 | 20 | int:RCOR1 |
| Interaction | ZYX interactions | TANC2 FKBP15 DLGAP5 TNRC6B CEP192 YWHAB SPICE1 ALMS1 CLMN TNRC6A MACF1 TLN2 ZFR LIMCH1 ARHGAP21 EP300 | 1.46e-08 | 329 | 166 | 16 | int:ZYX |
| Interaction | SRF interactions | ZNF518A BPTF MRTFB UBP1 ARID2 EPC1 NFYA NCOA1 TMPO FOXG1 ZNF292 | 2.14e-08 | 139 | 166 | 11 | int:SRF |
| Interaction | HDAC1 interactions | ATRX ZFYVE16 ZGRF1 UBR4 ZMYM2 TNRC6B NUP214 REST ECPAS WDR26 MEF2A JMJD1C HMG20A RLF BPTF MRTFB DST ALMS1 TET1 PITX2 TNRC6A NFYA ANKRD17 KIF2A MGA ARHGAP21 EP300 FOXG1 TBP | 2.89e-08 | 1108 | 166 | 29 | int:HDAC1 |
| Interaction | ZFP36 interactions | MAGED1 TNRC6B NUP214 CEP192 YWHAB TNRC6A MARF1 OTUD4 ANKRD17 PUM1 CNOT4 | 3.19e-07 | 181 | 166 | 11 | int:ZFP36 |
| Interaction | YWHAH interactions | TANC2 KIF21B TRIO NHSL2 EXPH5 SPPL3 EPB41L5 CEP192 HUWE1 WDR26 YWHAB FAM83B DST ALMS1 CLMN STARD9 TET1 NCOA1 ANKRD17 MACF1 KIF2A LIMCH1 PATJ PUM1 MAP4K4 ARHGAP21 CNOT4 | 3.47e-07 | 1102 | 166 | 27 | int:YWHAH |
| Interaction | NANOG interactions | WAPL MAGED1 LEMD3 ZMYM2 MUC16 REST HUWE1 ECPAS JMJD1C PHC1 BPTF PPP2R3A TET1 ZFR PUM1 MGA EP300 | 5.05e-07 | 481 | 166 | 17 | int:NANOG |
| Interaction | H3C3 interactions | WAPL ATRX DLGAP5 ZMYM2 JMJD1C PHC1 HMG20A BLM RLF FSIP2 FBXO38 BPTF SBNO1 ARID2 TMPO MGA ZNF292 | 7.51e-07 | 495 | 166 | 17 | int:H3C3 |
| Interaction | SYNE3 interactions | TANC2 LEMD3 ST7 EXPH5 TNRC6B NUP214 CEP192 SPICE1 FAM83B DST ALMS1 CLMN TNRC6A MACF1 PUM1 ARHGAP21 | 8.64e-07 | 444 | 166 | 16 | int:SYNE3 |
| Interaction | H2BC21 interactions | UBQLN1 ATRX ZMYM2 REST HUWE1 JMJD1C PHC1 PHC2 HMG20A BLM RLF BPTF USF3 MRTFB ARID2 TET1 MAP4K4 EP300 ZNF292 WDR48 | 1.24e-06 | 696 | 166 | 20 | int:H2BC21 |
| Interaction | H3C1 interactions | WAPL SUPT20H ATRX LEMD3 UBR4 NACA DLGAP5 ZMYM2 SRPK1 TSSC4 YWHAB JMJD1C BLM RLF BPTF ARID2 TMPO ZFR MBD5 MGA EP300 TBP ZNF292 | 1.43e-06 | 901 | 166 | 23 | int:H3C1 |
| Interaction | MYCBP2 interactions | KIF21B ZNF618 UBR4 HUWE1 DCX YWHAB DST MACF1 KIF2A LIMCH1 MAP4K4 UNC79 ARHGAP21 WDR48 | 1.51e-06 | 355 | 166 | 14 | int:MYCBP2 |
| Interaction | POU5F1 interactions | WAPL LEMD3 UBR4 NACA ZMYM2 MUC16 HUWE1 ECPAS JMJD1C PHC1 BPTF PPP2R3A UBP1 TET1 TMPO ANKRD17 MGA TBP | 1.65e-06 | 584 | 166 | 18 | int:POU5F1 |
| Interaction | CNOT2 interactions | SPPL3 TNRC6B CEP192 WDR26 JMJD1C ALMS1 TNRC6A ANKRD17 PUM1 CNOT4 | 2.27e-06 | 178 | 166 | 10 | int:CNOT2 |
| Interaction | FBXO22 interactions | KIF21B WAPL SUPT20H EXPH5 NUP214 ECPAS BLM ARID2 TMPO ZFR KIF2A RP1 LIMCH1 PUM1 MAP4K4 ARHGAP21 ZNF292 | 2.45e-06 | 540 | 166 | 17 | int:FBXO22 |
| Interaction | RNF43 interactions | URI1 MAGED1 ZFYVE16 LEMD3 EXPH5 EPB41L5 TNRC6B YWHAB JMJD1C FAM83B ALMS1 TNRC6A MACF1 MAP4K4 ARHGAP21 | 2.64e-06 | 427 | 166 | 15 | int:RNF43 |
| Interaction | CPAP interactions | ARMT1 STRN3 TRIO IBSP TNRC6B CEP192 YWHAB SPICE1 ALMS1 TNRC6A | 2.78e-06 | 182 | 166 | 10 | int:CPAP |
| Interaction | MAPRE3 interactions | CTTNBP2 TRIO DLGAP5 SPICE1 FAM83B DST MARF1 MACF1 KIF2A MAP4K4 ARHGAP21 | 3.37e-06 | 230 | 166 | 11 | int:MAPRE3 |
| Interaction | HDAC4 interactions | TANC2 CACNA1B MAGED1 ATRX TRIO STRBP ITGB1BP1 UBR4 TNRC6B NUP214 REST HUWE1 YWHAB MEF2A CLMN UBP1 OTUD4 TLN2 ZFR LIMCH1 | 3.41e-06 | 744 | 166 | 20 | int:HDAC4 |
| Interaction | TNIK interactions | TANC2 FKBP15 STRN3 CTTNBP2 TRIO ZMYM2 HUWE1 DCX DST MACF1 KIF2A MGA MAP4K4 ARHGAP21 | 3.44e-06 | 381 | 166 | 14 | int:TNIK |
| Interaction | CPEB1 interactions | 3.46e-06 | 146 | 166 | 9 | int:CPEB1 | |
| Interaction | PPIA interactions | KRT3 STRN3 TRIO ZFYVE16 NACA KPRP EPB41L5 TNRC6B SRPK1 HUWE1 ECPAS YWHAB CRMP1 BLM BPTF MISP DST STARD9 ARID2 MACF1 TLN2 ARHGAP21 | 4.00e-06 | 888 | 166 | 22 | int:PPIA |
| Interaction | NUP43 interactions | ZMYM2 TNRC6B NUP214 JMJD1C ZNF518A HELB BLM RLF FSIP2 BPTF MRTFB DST ARID2 EPC1 MARF1 KIF2A MGA ZNF292 | 4.25e-06 | 625 | 166 | 18 | int:NUP43 |
| Interaction | H2BC8 interactions | WAPL ING3 ATRX LEMD3 DLGAP5 ZMYM2 YWHAB PHC1 PHC2 HMG20A BLM RLF BPTF SBNO1 TMPO MGA ZNF292 | 5.79e-06 | 576 | 166 | 17 | int:H2BC8 |
| Interaction | USF1 interactions | 6.52e-06 | 85 | 166 | 7 | int:USF1 | |
| Interaction | CNOT3 interactions | TNRC6B HUWE1 TSSC4 EPC1 TNRC6A MARF1 ANKRD17 PUM1 EP300 CNOT4 | 8.69e-06 | 207 | 166 | 10 | int:CNOT3 |
| Interaction | GATA5 interactions | 9.72e-06 | 17 | 166 | 4 | int:GATA5 | |
| Interaction | KCNA3 interactions | CACNA1B AFF2 ZFYVE16 EXPH5 NACA EPB41L5 TNRC6B NUP214 ECPAS JMJD1C SPICE1 FAM83B DST TMPO ANKRD17 MACF1 TLN2 RP1 PATJ MAP4K4 ARHGAP21 | 1.02e-05 | 871 | 166 | 21 | int:KCNA3 |
| Interaction | CEP85 interactions | 1.14e-05 | 169 | 166 | 9 | int:CEP85 | |
| Interaction | R3HDM2 interactions | 1.17e-05 | 129 | 166 | 8 | int:R3HDM2 | |
| Interaction | CNOT6L interactions | 1.18e-05 | 93 | 166 | 7 | int:CNOT6L | |
| Interaction | TEAD1 interactions | 1.57e-05 | 176 | 166 | 9 | int:TEAD1 | |
| Interaction | CNOT4 interactions | 1.58e-05 | 65 | 166 | 6 | int:CNOT4 | |
| Interaction | NFYC interactions | 1.65e-05 | 177 | 166 | 9 | int:NFYC | |
| Interaction | NAA40 interactions | FKBP15 STRN3 WAPL ATRX ZFYVE16 NACA DLGAP5 ZMYM2 TNRC6B NUP214 YWHAB MRTFB DST ALMS1 CLMN ARID2 TMPO ANKRD17 MACF1 ZFR LIMCH1 ARHGAP21 | 1.82e-05 | 978 | 166 | 22 | int:NAA40 |
| Interaction | HNF4A interactions | 1.82e-05 | 275 | 166 | 11 | int:HNF4A | |
| Interaction | ALG13 interactions | 2.15e-05 | 183 | 166 | 9 | int:ALG13 | |
| Interaction | AKR7L interactions | 2.84e-05 | 72 | 166 | 6 | int:AKR7L | |
| Interaction | HNF1B interactions | 2.89e-05 | 190 | 166 | 9 | int:HNF1B | |
| Interaction | GSK3A interactions | TRIO TNRC6B SRPK1 CEP192 YWHAB SPICE1 HELB MISP DST ALMS1 SBNO1 TNRC6A MACF1 ARHGAP21 | 3.15e-05 | 464 | 166 | 14 | int:GSK3A |
| Interaction | SUMO2 interactions | WAPL ATRX UBR4 NACA ZMYM2 NUP214 HUWE1 YWHAB BLM FBXO38 BPTF DST ARID2 TMPO KIF2A EP300 | 3.17e-05 | 591 | 166 | 16 | int:SUMO2 |
| Interaction | ASCL1 interactions | 3.34e-05 | 45 | 166 | 5 | int:ASCL1 | |
| Interaction | VASP interactions | MAGED1 UBR4 TNRC6B CEP192 ALMS1 UBP1 TNRC6A LIMCH1 PATJ ARHGAP21 TBP | 3.37e-05 | 294 | 166 | 11 | int:VASP |
| Interaction | SKA3 interactions | 3.40e-05 | 194 | 166 | 9 | int:SKA3 | |
| Interaction | UNK interactions | UBQLN1 TNRC6B HUWE1 YWHAB DST ALMS1 TNRC6A OTUD4 TMPO ANKRD17 LIMCH1 PUM1 MGA | 3.48e-05 | 408 | 166 | 13 | int:UNK |
| Interaction | CPEB4 interactions | 4.62e-05 | 156 | 166 | 8 | int:CPEB4 | |
| Interaction | AMOT interactions | FKBP15 UBR4 TNRC6B CEP192 YWHAB SPICE1 ALMS1 TNRC6A PATJ MAP4K4 EP300 | 5.76e-05 | 312 | 166 | 11 | int:AMOT |
| Interaction | SOX7 interactions | 5.96e-05 | 82 | 166 | 6 | int:SOX7 | |
| Interaction | SFN interactions | TANC2 EXPH5 EPB41L5 CEP192 TEX14 WDR26 YWHAB FAM83B DST ALMS1 CLMN ANKRD17 MACF1 KIF2A PUM1 MAP4K4 ARHGAP21 | 5.99e-05 | 692 | 166 | 17 | int:SFN |
| Interaction | ETS1 interactions | 6.51e-05 | 121 | 166 | 7 | int:ETS1 | |
| Interaction | AR interactions | KRT3 WAPL MAGED1 ATRX EXPH5 ZMYM2 HUWE1 ECPAS MEF2A JMJD1C ARID2 EPC1 MED12L NCOA1 ZFR LIMCH1 MGA EP300 FOXG1 TBP WDR48 | 6.86e-05 | 992 | 166 | 21 | int:AR |
| Interaction | SFMBT1 interactions | 7.44e-05 | 53 | 166 | 5 | int:SFMBT1 | |
| Interaction | GARRE1 interactions | 7.47e-05 | 167 | 166 | 8 | int:GARRE1 | |
| Interaction | LATS1 interactions | KPRP TNRC6B CEP192 REST YWHAB SPICE1 ALMS1 TNRC6A OTUD4 PATJ PUM1 MGA MAP4K4 | 7.52e-05 | 440 | 166 | 13 | int:LATS1 |
| Interaction | GPBP1L1 interactions | 7.78e-05 | 86 | 166 | 6 | int:GPBP1L1 | |
| Interaction | MKRN2 interactions | ATRX TRIO TNRC6B CEP192 SEMA3A ALMS1 TNRC6A MARF1 OTUD4 MACF1 PUM1 EP300 | 8.65e-05 | 385 | 166 | 12 | int:MKRN2 |
| Interaction | CBX3 interactions | WAPL ATRX LEMD3 ZMYM2 SRPK1 REST ZNF518A BLM RLF SBNO1 ARID2 MACF1 MGA MAP4K4 EP300 ZNF292 | 9.06e-05 | 646 | 166 | 16 | int:CBX3 |
| Interaction | YWHAG interactions | TANC2 KIF21B NHSL2 EXPH5 EPB41L5 SRPK1 CEP192 HUWE1 YWHAB SPICE1 FAM83B DST ALMS1 CLMN STARD9 TET1 ANKRD17 MACF1 KIF2A PATJ PUM1 MAP4K4 ARHGAP21 CNOT4 | 9.06e-05 | 1248 | 166 | 24 | int:YWHAG |
| Interaction | BRCA1 interactions | WAPL TRIO UBR4 NACA TNRC6B NUP214 HUWE1 ECPAS BLM FBXO38 BPTF DST ALMS1 TPP1 CENPI TNRC6A NFYA NCOA1 ZFR KIF2A MAP4K4 ARHGAP21 EP300 WDR48 | 9.18e-05 | 1249 | 166 | 24 | int:BRCA1 |
| Interaction | MEX3B interactions | 9.64e-05 | 222 | 166 | 9 | int:MEX3B | |
| Interaction | UBE2B interactions | 1.00e-04 | 90 | 166 | 6 | int:UBE2B | |
| Interaction | AFDN interactions | EPB41L5 TNRC6B CEP192 YWHAB FAM83B DST TNRC6A MACF1 PATJ MAP4K4 ARHGAP21 | 1.03e-04 | 333 | 166 | 11 | int:AFDN |
| Interaction | ANKRD17 interactions | 1.10e-04 | 226 | 166 | 9 | int:ANKRD17 | |
| Interaction | PATL1 interactions | 1.12e-04 | 177 | 166 | 8 | int:PATL1 | |
| Interaction | FHL2 interactions | POU6F2 WAPL ING3 KPRP EPB41L5 MISP MRTFB ALMS1 ANKRD17 ZFR PATJ EP300 | 1.13e-04 | 396 | 166 | 12 | int:FHL2 |
| Interaction | TNRC6B interactions | MAGED1 TNRC6B CEP192 ALMS1 TNRC6A MARF1 OTUD4 ANKRD17 PUM1 CNOT4 | 1.20e-04 | 282 | 166 | 10 | int:TNRC6B |
| Interaction | MAGEA1 interactions | 1.35e-04 | 95 | 166 | 6 | int:MAGEA1 | |
| Interaction | PUM1 interactions | MAGED1 TNRC6B CLOCK YWHAB TNRC6A OTUD4 ANKRD17 PUM1 EP300 FOXG1 | 1.38e-04 | 287 | 166 | 10 | int:PUM1 |
| Interaction | LURAP1 interactions | 1.42e-04 | 137 | 166 | 7 | int:LURAP1 | |
| Interaction | EGLN3 interactions | URI1 WAPL MAGED1 ZFYVE16 LEMD3 FPGS UBR4 DLGAP5 CEP192 TSSC4 ECPAS WDR26 YWHAB JMJD1C BLM TPP1 OTUD4 TMPO ANKRD17 KIF2A PUM1 MGA MAP4K4 ARHGAP21 | 1.61e-04 | 1296 | 166 | 24 | int:EGLN3 |
| Interaction | EPB41L4A interactions | 1.63e-04 | 140 | 166 | 7 | int:EPB41L4A | |
| Interaction | CBX5 interactions | 1.84e-04 | 356 | 166 | 11 | int:CBX5 | |
| Interaction | TBC1D13 interactions | 1.87e-04 | 14 | 166 | 3 | int:TBC1D13 | |
| Interaction | FAM120C interactions | 1.89e-04 | 191 | 166 | 8 | int:FAM120C | |
| Interaction | EYA4 interactions | 1.91e-04 | 243 | 166 | 9 | int:EYA4 | |
| Interaction | STK26 interactions | 1.96e-04 | 192 | 166 | 8 | int:STK26 | |
| Interaction | DAZL interactions | 2.02e-04 | 145 | 166 | 7 | int:DAZL | |
| Interaction | PPP1CA interactions | TANC2 URI1 ZFYVE16 NACA CEP192 HUWE1 CLOCK DCX YWHAB MEF2A PHC1 TMPO KIF2A MAP4K4 EP300 MYO16 | 2.12e-04 | 696 | 166 | 16 | int:PPP1CA |
| Interaction | NUP35 interactions | LEMD3 ST7 MAMLD1 TNRC6B NUP214 JMJD1C TNRC6A TMPO ANKRD17 ZFR PUM1 EP300 | 2.12e-04 | 424 | 166 | 12 | int:NUP35 |
| Interaction | MEAF6 interactions | 2.22e-04 | 104 | 166 | 6 | int:MEAF6 | |
| Interaction | RNF214 interactions | 2.22e-04 | 104 | 166 | 6 | int:RNF214 | |
| Interaction | ACTR3 interactions | 2.26e-04 | 305 | 166 | 10 | int:ACTR3 | |
| Interaction | NUP62CL interactions | 2.37e-04 | 37 | 166 | 4 | int:NUP62CL | |
| Interaction | SLMAP interactions | 2.39e-04 | 149 | 166 | 7 | int:SLMAP | |
| Interaction | CEP120 interactions | 2.47e-04 | 106 | 166 | 6 | int:CEP120 | |
| Interaction | SOX2 interactions | MAGED1 ST7 UBR4 ZMYM2 SRPK1 NUP214 CLOCK WDR26 MEF2A JMJD1C PHC2 HMG20A RLF BPTF ARID2 TNRC6A MARF1 TMPO ANKRD17 MACF1 ZFR KIF2A ARHGAP21 EP300 ZNF292 | 2.58e-04 | 1422 | 166 | 25 | int:SOX2 |
| Interaction | TRRAP interactions | FLG WAPL SUPT20H ING3 STRBP NACA KPRP ZMYM2 NUP214 MUC13 ECPAS CLOCK YWHAB FBXO38 EPC1 MGA ARHGAP21 | 2.91e-04 | 790 | 166 | 17 | int:TRRAP |
| Interaction | FAM193A interactions | 3.00e-04 | 71 | 166 | 5 | int:FAM193A | |
| Interaction | KRT8 interactions | KRT3 UBR4 TNRC6B CEP192 YWHAB SPICE1 FAM83B ALMS1 TNRC6A OTUD4 PUM1 ARHGAP21 | 3.04e-04 | 441 | 166 | 12 | int:KRT8 |
| Interaction | SMG7 interactions | TNRC6B JMJD1C SPICE1 HMG20A TET1 TNRC6A OTUD4 NCOA1 ANKRD17 PUM1 | 3.23e-04 | 319 | 166 | 10 | int:SMG7 |
| Interaction | DIRAS3 interactions | 3.32e-04 | 262 | 166 | 9 | int:DIRAS3 | |
| Interaction | H2BC9 interactions | ATRX DLGAP5 REST FSIP2 BPTF USF3 DST SBNO1 UBP1 TMPO RP1 MBD5 | 3.36e-04 | 446 | 166 | 12 | int:H2BC9 |
| Interaction | CNOT8 interactions | 3.64e-04 | 74 | 166 | 5 | int:CNOT8 | |
| Interaction | NME7 interactions | 3.68e-04 | 160 | 166 | 7 | int:NME7 | |
| Interaction | ZFP36L2 interactions | 3.71e-04 | 211 | 166 | 8 | int:ZFP36L2 | |
| Interaction | GPBP1 interactions | 3.87e-04 | 75 | 166 | 5 | int:GPBP1 | |
| Interaction | APC interactions | STRN3 EXPH5 NUP214 YWHAB FAM83B DST ANKRD17 MACF1 RP1 MBD5 ARHGAP21 | 3.93e-04 | 389 | 166 | 11 | int:APC |
| GeneFamily | SIBLING family | 2.11e-06 | 5 | 109 | 3 | 1279 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.36e-04 | 17 | 109 | 3 | 486 | |
| GeneFamily | EF-hand domain containing | 3.64e-04 | 219 | 109 | 7 | 863 | |
| GeneFamily | LEM domain containing | 7.42e-04 | 7 | 109 | 2 | 1087 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.42e-04 | 7 | 109 | 2 | 785 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 7.42e-04 | 7 | 109 | 2 | 1350 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.00e-04 | 181 | 109 | 6 | 694 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.85e-04 | 8 | 109 | 2 | 939 | |
| GeneFamily | Doublecortin superfamily | 1.57e-03 | 10 | 109 | 2 | 1369 | |
| GeneFamily | PHD finger proteins | 2.15e-03 | 90 | 109 | 4 | 88 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.68e-03 | 46 | 109 | 3 | 622 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.59e-03 | 15 | 109 | 2 | 696 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 6.37e-03 | 20 | 109 | 2 | 1371 | |
| GeneFamily | CD molecules|Mucins | 7.02e-03 | 21 | 109 | 2 | 648 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STRN3 URI1 WAPL SUPT20H ATRX TRIO ZFYVE16 DLGAP5 MAMLD1 ZMYM2 CLOCK MBOAT2 MEF2A BLM RLF BPTF PPP2R3A HEG1 MGAT5 DST OTUD4 NCOA1 ANKRD17 MACF1 BICRAL KIF2A PUM1 CNOT4 ZNF292 | 1.25e-13 | 856 | 165 | 29 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STRN3 WAPL ATRX TRIO MAMLD1 ZMYM2 CLOCK BLM BPTF PPP2R3A HEG1 MGAT5 DST MARF1 NCOA1 ANKRD17 KIF2A LIMCH1 PUM1 CNOT4 ZNF292 | 2.05e-12 | 466 | 165 | 21 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FLG WAPL ATRX EXPH5 PHC2 BPTF HEG1 DST NFYA OTUD4 BICRAL KIF2A PUM1 CNOT4 | 7.51e-09 | 300 | 165 | 14 | M8702 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | ST7 STXBP5 RALGAPA2 WDR26 JMJD1C PHC1 MGAT5 CGRRF1 EPC1 MARF1 NCOA1 TMPO PRMT9 ZFR MAP4K4 EP300 ZNF292 WDR48 | 3.20e-07 | 680 | 165 | 18 | M41089 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B URI1 WAPL ATRX ITGB1BP1 UBR4 MBP HLA-H TNRC6B REST HUWE1 WDR26 YWHAB JMJD1C BPTF HEG1 SBNO1 TPP1 ARID2 EPC1 OTUD4 NCOA1 MACF1 ZFR KIF2A EP300 ZNF292 | 6.94e-07 | 1492 | 165 | 27 | M40023 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | TNRC6B MEF2A ZNF518A PPP2R3A DST TNRC6A NCOA1 UBR3 LIMCH1 MBD5 | 8.56e-07 | 208 | 165 | 10 | M39233 |
| Coexpression | GSE27786_BCELL_VS_CD4_TCELL_DN | 4.84e-06 | 198 | 165 | 9 | M4800 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | MAGED1 EXPH5 PLXND1 HUWE1 RALGAPA2 CLOCK CHRM2 MBOAT2 PHC2 MISP USF3 TET1 NCOA1 TMPO ANKRD17 KIF2A LIMCH1 MAP4K4 | 6.84e-06 | 845 | 165 | 18 | M18090 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CTTNBP2 ING3 ZFYVE16 LEMD3 ECPAS CLOCK ZNF518A EDEM3 MGAT5 DST TPP1 MED12L UBR3 MACF1 ZFR KDM7A MBD5 EP300 | 7.90e-06 | 854 | 165 | 18 | M1533 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 CELF4 UBQLN1 ATRX EXPH5 STXBP5 MBP HUWE1 ECPAS PHC2 CRMP1 USF3 DST SBNO1 TPP1 KDM7A UNC79 UNC80 ZNF292 | 8.63e-06 | 946 | 165 | 19 | M39169 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CTTNBP2 ING3 ZFYVE16 LEMD3 ECPAS CLOCK ZNF518A EDEM3 MGAT5 DST TPP1 MED12L UBR3 MACF1 ZFR KDM7A MBD5 EP300 | 1.34e-05 | 888 | 165 | 18 | MM1018 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SUPT20H FMOD STRBP MBP EPB41L5 ZMYM2 TNRC6B RALGAPA2 ZNF518A MRTFB ALMS1 RBMS3 CLMN ARID2 BICRAL LIMCH1 PATJ | 1.44e-05 | 807 | 165 | 17 | M16651 |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 1.52e-05 | 174 | 165 | 8 | M6881 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ATRX ZMYM2 TNRC6B CLOCK TET1 UBR3 LIMCH1 MGA ARHGAP21 ZNF292 | 1.58e-05 | 289 | 165 | 10 | M2196 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TANC2 IL15 WAPL MBP MEF2A JMJD1C RLF FBXO38 DST SBNO1 CGRRF1 NFYA NCOA1 PUM1 EP300 CNOT4 WDR48 | 1.82e-05 | 822 | 165 | 17 | M6782 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.94e-05 | 180 | 165 | 8 | M8239 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CACNA1B CELF4 MAGED1 STRBP ZGRF1 DLGAP5 SSTR2 MBOAT2 PHC1 CRMP1 BLM ALMS1 CENPI TMPO UNC79 | 2.79e-05 | 680 | 165 | 15 | MM456 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SUPT20H TRIO CEP192 PLXND1 MEF2A TLR8 ZNF518A BPTF TMPO MACF1 CNOT4 | 2.95e-05 | 378 | 165 | 11 | M41174 |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP | 3.20e-05 | 193 | 165 | 8 | M6130 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 3.98e-05 | 199 | 165 | 8 | M3186 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 4.12e-05 | 200 | 165 | 8 | M9463 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_DN | 4.12e-05 | 200 | 165 | 8 | M5963 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP | 4.12e-05 | 200 | 165 | 8 | M4584 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN | 4.12e-05 | 200 | 165 | 8 | M8398 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP | 4.12e-05 | 200 | 165 | 8 | M6473 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 4.12e-05 | 200 | 165 | 8 | M8997 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 5.19e-05 | 152 | 165 | 7 | M39243 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 6.21e-05 | 212 | 165 | 8 | M39221 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 KIF21B FKBP15 CELF4 AFF2 ATRX STXBP5 SSTR2 DCX CRMP1 SEMA3A FSIP2 PPP2R3A MGAT5 RBMS3 TNRC6A OTUD4 TLN2 UNC79 | 7.26e-05 | 1106 | 165 | 19 | M39071 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 1.26e-04 | 175 | 165 | 7 | M336 | |
| Coexpression | GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP | 1.50e-04 | 180 | 165 | 7 | M6718 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.54e-04 | 43 | 165 | 4 | M1551 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.54e-04 | 43 | 165 | 4 | MM666 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.71e-04 | 184 | 165 | 7 | M9005 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | 1.88e-04 | 389 | 165 | 10 | M39073 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | STRN3 MAGED1 SPPL3 TNRC6B REST MBOAT2 RBMS3 TNRC6A NFYA KIF2A PUM1 | 1.92e-04 | 467 | 165 | 11 | M1347 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 2.15e-04 | 86 | 165 | 5 | M39248 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.37e-04 | 137 | 165 | 6 | M39241 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN | 2.44e-04 | 195 | 165 | 7 | M9508 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 2.44e-04 | 195 | 165 | 7 | M1110 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.60e-04 | 197 | 165 | 7 | M5347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | STRN3 MAGED1 SPPL3 TNRC6B REST MBOAT2 RBMS3 TNRC6A NFYA KIF2A PUM1 | 2.61e-04 | 484 | 165 | 11 | MM999 |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP | 2.68e-04 | 198 | 165 | 7 | M9929 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 2.77e-04 | 199 | 165 | 7 | M5970 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 2.77e-04 | 199 | 165 | 7 | M8082 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.77e-04 | 199 | 165 | 7 | M8606 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.85e-04 | 200 | 165 | 7 | M9449 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN | 2.85e-04 | 200 | 165 | 7 | M8056 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 2.85e-04 | 200 | 165 | 7 | M387 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 2.85e-04 | 200 | 165 | 7 | M9763 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 2.85e-04 | 200 | 165 | 7 | M5069 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN | 2.85e-04 | 200 | 165 | 7 | M5274 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN | 2.85e-04 | 200 | 165 | 7 | M7909 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 2.85e-04 | 200 | 165 | 7 | M6533 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 2.85e-04 | 200 | 165 | 7 | M7839 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 2.85e-04 | 200 | 165 | 7 | M9260 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 2.85e-04 | 200 | 165 | 7 | M5617 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 2.86e-04 | 335 | 165 | 9 | M10277 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP | 2.98e-04 | 143 | 165 | 6 | M8819 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_DN | 3.09e-04 | 144 | 165 | 6 | M2535 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 3.10e-04 | 268 | 165 | 8 | M45696 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 3.51e-04 | 207 | 165 | 7 | MM475 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | KIF21B CELF4 CTTNBP2 MUC16 SSTR2 DCX CRMP1 PPP2R3A MED12L BICRAL UNC79 | 3.80e-04 | 506 | 165 | 11 | M39067 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 3.94e-04 | 211 | 165 | 7 | MM17081 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | ARMT1 ATRX ECPAS HMG20A MRTFB MARF1 NCOA1 ANKRD17 MACF1 LIMCH1 | 4.08e-04 | 429 | 165 | 10 | M29 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | TANC2 CACNA1B FLG URI1 FMOD EXPH5 STXBP5 DGKG LINGO2 WDR26 MBOAT2 TET1 OTUD4 LIMCH1 CNGA3 | 4.30e-04 | 873 | 165 | 15 | M16009 |
| Coexpression | GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP | 4.58e-04 | 155 | 165 | 6 | M6500 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 5.07e-04 | 158 | 165 | 6 | M372 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CELF4 URI1 ING3 ATRX TRIO STRBP ZGRF1 DLGAP5 MBP MAMLD1 EPB41L5 CLOCK BPTF TNRC6A TMPO MACF1 EP300 ZNF292 | 9.42e-07 | 595 | 165 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | ATRX EPB41L5 NUP214 HUWE1 WDR26 PPP2R3A SBNO1 ARID2 MED12L OTUD4 UBR3 KIF2A LIMCH1 ZNF292 | 1.46e-06 | 375 | 165 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | ATRX TRIO NHSL2 ZNF618 REST MEF2A JMJD1C RLF HEG1 CSF1R RBMS3 CLMN STARD9 TET1 TNRC6A ZFR MRAP2 PUM1 MGA CNOT4 | 3.51e-06 | 790 | 165 | 20 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TEPSIN WAPL ATRX CEP192 ECPAS PHC1 ZNF518A RLF DST ALMS1 ST6GALNAC5 TET1 CENPI MAP4K4 ZNF292 | 4.09e-06 | 469 | 165 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ATRX ST7 STRBP STXBP5 MAMLD1 EPB41L5 ZMYM2 TNRC6B HUWE1 ZNF518A EDEM3 HEG1 MRTFB ALMS1 CGRRF1 EPC1 KIF2A ARHGAP21 CNOT4 ZNF292 | 7.45e-06 | 831 | 165 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | URI1 ING3 ATRX ZGRF1 DLGAP5 MAMLD1 ZMYM2 REST ECPAS BPTF TET1 TMPO UBR3 MACF1 MGA TBP ZNF292 | 8.58e-06 | 629 | 165 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ARMT1 ATRX EPB41L5 NUP214 HUWE1 ECPAS DCX BPTF ARID2 MED12L KIF2A MGA CNOT4 | 8.76e-06 | 379 | 165 | 13 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | URI1 ATRX TRIO ZGRF1 REST ECPAS JMJD1C FBXO38 BPTF ARID2 ST6GALNAC5 TMPO ANKRD17 MACF1 TBP ZNF292 | 8.79e-06 | 564 | 165 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | UBQLN1 ATRX EPB41L5 TNRC6B ECPAS NFYA OTUD4 TMPO PRMT9 ZFR PUM1 MGA WDR48 | 3.22e-05 | 429 | 165 | 13 | gudmap_developingGonad_e14.5_ testes_1000_k5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | URI1 WAPL ATRX ZNF618 STRBP ZGRF1 ZMYM2 CEP192 PHC1 CRMP1 BLM BPTF HEG1 ALMS1 SBNO1 TET1 CENPI TMPO MACF1 KIF2A MBD5 ARHGAP21 CNOT4 ZNF292 | 4.08e-05 | 1257 | 165 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | UBQLN1 ATRX NHSL2 ECPAS PPP2R3A OTUD4 TMPO PRMT9 ZFR KIF2A PUM1 MGA | 4.18e-05 | 378 | 165 | 12 | gudmap_developingGonad_e16.5_testes_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | FMOD ATRX TRIO NHSL2 MEF2A JMJD1C RLF HEG1 CSF1R RBMS3 CLMN STARD9 TET1 TNRC6A MRAP2 PUM1 MGA CNOT4 | 5.20e-05 | 799 | 165 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | URI1 WAPL AFF2 ATRX ZNF618 STRBP ZGRF1 ZMYM2 CEP192 PHC1 CRMP1 BLM BPTF HEG1 ALMS1 SBNO1 TET1 CENPI PITX2 TMPO MACF1 KIF2A MBD5 ARHGAP21 CNOT4 ZNF292 | 6.01e-05 | 1459 | 165 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | ARMT1 SUPT20H UBQLN1 ATRX NHSL2 EPB41L5 REST PPP2R3A OTUD4 TMPO ZFR KIF2A PUM1 MGA | 6.26e-05 | 524 | 165 | 14 | gudmap_developingGonad_e12.5_testes_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | CTTNBP2 ATRX NHSL2 ZNF618 REST DCX JMJD1C CRMP1 RLF HEG1 RBMS3 CLMN ST6GALNAC5 TET1 PITX2 PUM1 MGA CNOT4 | 6.70e-05 | 815 | 165 | 18 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 CACNA1B CELF4 ZNF618 TNRC6B NUP214 HUWE1 ECPAS WDR26 DCX CRMP1 SBNO1 ST6GALNAC5 PITX2 OTUD4 KIF2A PUM1 TCFL5 | 7.02e-05 | 818 | 165 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TANC2 STRBP ZGRF1 CEP192 HUWE1 TEX14 RALGAPA2 ZNF518A SPICE1 BLM ALMS1 TET1 CENPI MED12L OTUD4 PRMT9 MGA TCFL5 | 7.24e-05 | 820 | 165 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ATRX HUWE1 TEX14 ECPAS MEF2A JMJD1C ZNF518A RLF HEG1 ALMS1 SBNO1 ANKRD17 INSYN2B PUM1 MGA TCFL5 CNOT4 | 1.19e-04 | 776 | 165 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATRX ZMYM2 ZNF518A BLM HEG1 USF3 ALMS1 KIF2A ARHGAP21 ZNF292 | 1.66e-04 | 311 | 165 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ATRX TRIO NHSL2 ZNF618 REST JMJD1C RLF HEG1 CSF1R RBMS3 CLMN STARD9 TET1 TNRC6A PUM1 MGA CNOT4 | 1.73e-04 | 801 | 165 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.81e-04 | 201 | 165 | 8 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | ATRX CCDC30 NHSL2 ZNF618 REST HUWE1 TEX14 JMJD1C RLF HEG1 CLMN TET1 ANKRD17 INSYN2B PUM1 MGA CNOT4 | 1.81e-04 | 804 | 165 | 17 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | CACNA1B CTTNBP2 ATRX TRIO NUP214 ECPAS DCX CRMP1 RLF SEMA3A DST OTUD4 TLN2 INSYN2B DMP1 ZNF292 PYGO1 | 1.86e-04 | 806 | 165 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | ARMT1 SUPT20H UBQLN1 ATRX NHSL2 EPB41L5 REST HUWE1 TEX14 PPP2R3A PITX2 OTUD4 TMPO ZFR KIF2A PUM1 MGA | 2.25e-04 | 819 | 165 | 17 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.25e-04 | 323 | 165 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | WAPL STRBP ZGRF1 CEP192 REST TEX14 PHC1 ZNF518A SPICE1 HELB BLM ALMS1 TET1 CENPI MED12L OTUD4 PRMT9 | 2.35e-04 | 822 | 165 | 17 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | STRBP CEP192 TEX14 PHC1 ZNF518A SPICE1 BLM SBNO1 OTUD4 PRMT9 | 2.88e-04 | 333 | 165 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.31e-04 | 339 | 165 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KIF21B AFF2 ATRX STRBP MAMLD1 EPB41L5 ZMYM2 SRPK1 RALGAPA2 DCX PGAP6 PHC1 PHC2 CRMP1 BPTF HEG1 ALMS1 PRMT9 ZFR KIF2A ARHGAP21 TBP PYGO1 | 3.94e-04 | 1370 | 165 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 3.99e-04 | 413 | 165 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.16e-04 | 349 | 165 | 10 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TANC2 IL15 AFF2 CCDC30 ZNF618 EPB41L5 MUC16 ZNF692 MBOAT2 SEMA3A DST STARD9 INSYN2B PATJ ARHGAP21 ZNF292 | 4.59e-04 | 791 | 165 | 16 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.79e-04 | 127 | 165 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | WAPL STRBP ZGRF1 DLGAP5 CEP192 REST TEX14 PHC1 ZNF518A SPICE1 HELB BLM ALMS1 TET1 CENPI OTUD4 | 4.85e-04 | 795 | 165 | 16 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | ARMT1 ATRX EPB41L5 NUP214 HUWE1 ECPAS DCX BPTF DST ARID2 MED12L OTUD4 KIF2A PATJ MGA CNOT4 | 4.85e-04 | 795 | 165 | 16 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | ATRX NHSL2 ZNF618 REST TEX14 RLF SBNO1 CLMN TET1 PITX2 TNRC6A ANKRD17 PUM1 MGA TCFL5 CNOT4 | 5.62e-04 | 806 | 165 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.81e-04 | 432 | 165 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | CELF4 LEMD3 STRBP ITGB1BP1 MAMLD1 EPB41L5 ADCK2 RALGAPA2 DCX CRMP1 DST ALMS1 NCOA1 KDM7A FOXG1 TBP PYGO1 | 6.05e-04 | 893 | 165 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | CELF4 LEMD3 ZNF618 STRBP ITGB1BP1 MAMLD1 EPB41L5 ADCK2 DCX CRMP1 DST STARD9 NCOA1 FOXG1 PYGO1 | 6.07e-04 | 732 | 165 | 15 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | UBQLN1 ATRX MBP EPB41L5 TNRC6B TEX14 ECPAS NFYA OTUD4 TMPO PRMT9 ZFR PUM1 MGA TCFL5 WDR48 | 6.94e-04 | 822 | 165 | 16 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | URI1 UBQLN1 AFF2 ATRX IBSP MAMLD1 ZMYM2 ECPAS BLM UBP1 TET1 UBR3 MACF1 LIMCH1 MGA FOXG1 TBP ZNF292 | 7.04e-04 | 989 | 165 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 7.14e-04 | 137 | 165 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | URI1 WAPL ATRX ZNF618 ZMYM2 CEP192 DCX PHC1 ZNF518A BLM SEMA3A HEG1 ALMS1 TET1 CENPI TMPO UBR3 KIF2A MBD5 CNOT4 ZNF292 | 7.25e-04 | 1252 | 165 | 21 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | KIF21B ATRX STRBP JMJD1C TLR8 HEG1 CSF1R ALMS1 ZFR KIF2A PUM1 | 2.52e-10 | 198 | 167 | 11 | af4fb9eb2295c7b90624b38ba25619aa15254efa |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | KIF21B ATRX STRBP JMJD1C TLR8 HEG1 CSF1R ALMS1 ZFR KIF2A PUM1 | 2.52e-10 | 198 | 167 | 11 | ad39cce004867f083f8da1954e0cf5a263815184 |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | KIF21B ATRX STRBP JMJD1C TLR8 HEG1 CSF1R ALMS1 ZFR KIF2A PUM1 | 2.52e-10 | 198 | 167 | 11 | 62cbf4b29e8af4983fb47a17f96da62682a5137e |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-09 | 176 | 167 | 10 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.74e-09 | 138 | 167 | 9 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.70e-08 | 170 | 167 | 9 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.45e-08 | 190 | 167 | 9 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.09e-08 | 193 | 167 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.09e-08 | 193 | 167 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-08 | 195 | 167 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-08 | 195 | 167 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.62e-08 | 199 | 167 | 9 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-08 | 199 | 167 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.62e-08 | 199 | 167 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.91e-08 | 200 | 167 | 9 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.60e-07 | 159 | 167 | 8 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 3.20e-07 | 174 | 167 | 8 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.09e-07 | 185 | 167 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-07 | 185 | 167 | 8 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.30e-07 | 186 | 167 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 6.23e-07 | 190 | 167 | 8 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.23e-07 | 190 | 167 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.74e-07 | 192 | 167 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-07 | 192 | 167 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.29e-07 | 194 | 167 | 8 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.17e-07 | 200 | 167 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-06 | 165 | 167 | 7 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-06 | 173 | 167 | 7 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 175 | 167 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.20e-06 | 179 | 167 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.20e-06 | 179 | 167 | 7 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 5.59e-06 | 181 | 167 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.80e-06 | 182 | 167 | 7 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.80e-06 | 182 | 167 | 7 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.23e-06 | 184 | 167 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 6.23e-06 | 184 | 167 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 6.23e-06 | 184 | 167 | 7 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 6.23e-06 | 184 | 167 | 7 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 6.23e-06 | 184 | 167 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.23e-06 | 184 | 167 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-06 | 184 | 167 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 167 | 7 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 167 | 7 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 186 | 167 | 7 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 187 | 167 | 7 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 187 | 167 | 7 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.92e-06 | 187 | 167 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 6.92e-06 | 187 | 167 | 7 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 7.42e-06 | 189 | 167 | 7 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.68e-06 | 190 | 167 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.68e-06 | 190 | 167 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 191 | 167 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 191 | 167 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 191 | 167 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.22e-06 | 192 | 167 | 7 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.50e-06 | 193 | 167 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.09e-06 | 195 | 167 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.09e-06 | 195 | 167 | 7 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.40e-06 | 196 | 167 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 9.40e-06 | 196 | 167 | 7 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-06 | 196 | 167 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.72e-06 | 197 | 167 | 7 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.72e-06 | 197 | 167 | 7 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-05 | 198 | 167 | 7 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-05 | 198 | 167 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.00e-05 | 198 | 167 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.00e-05 | 198 | 167 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.04e-05 | 199 | 167 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.04e-05 | 199 | 167 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.07e-05 | 200 | 167 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-05 | 200 | 167 | 7 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-05 | 200 | 167 | 7 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-05 | 200 | 167 | 7 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-05 | 143 | 167 | 6 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-05 | 143 | 167 | 6 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 153 | 167 | 6 | 2731c3d4ac40ecc22108f8f3f45a069077159125 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.64e-05 | 155 | 167 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 160 | 167 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 160 | 167 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-05 | 165 | 167 | 6 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-05 | 165 | 167 | 6 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-05 | 165 | 167 | 6 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 166 | 167 | 6 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.02e-05 | 167 | 167 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 167 | 167 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 167 | 167 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 170 | 167 | 6 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 4.73e-05 | 172 | 167 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.32e-04 | 50 | 107 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.32e-04 | 50 | 107 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | STRN3 WAPL LEMD3 JMJD1C RLF MRTFB NFYA KIF2A PUM1 EP300 CNOT4 ZNF292 | 8.15e-09 | 180 | 165 | 12 | 4541_DN |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 5.03e-07 | 171 | 165 | 10 | 7535_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.91e-07 | 182 | 165 | 10 | 3887_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 9.85e-07 | 184 | 165 | 10 | 2321_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.38e-06 | 191 | 165 | 10 | 4279_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | TANC2 STRN3 ZMYM2 FBXO38 PPP2R3A NFYA TLN2 KDM7A CNOT4 WDR48 | 1.67e-06 | 195 | 165 | 10 | 1660_UP |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | FKBP15 STRN3 ZFYVE16 SRPK1 PPP2R3A OTUD4 KIF2A LIMCH1 PATJ CNOT4 | 1.67e-06 | 195 | 165 | 10 | 4660_DN |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 6.86e-06 | 180 | 165 | 9 | 3397_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.51e-06 | 182 | 165 | 9 | 3630_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 7.85e-06 | 183 | 165 | 9 | 7498_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.34e-06 | 187 | 165 | 9 | 4323_DN | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 1.15e-05 | 192 | 165 | 9 | 6164_DN | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.20e-05 | 193 | 165 | 9 | 5107_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.25e-05 | 194 | 165 | 9 | 6878_UP | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 7369_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 4728_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.42e-05 | 197 | 165 | 9 | 7194_DN | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A | 1.42e-05 | 197 | 165 | 9 | 2380_UP | |
| Drug | Succimer | KIF21B CACNA1B STRN3 ATRX ZFYVE16 LEMD3 STXBP5 TNRC6B REST WDR26 MEF2A JMJD1C ZNF518A BLM CLMN STARD9 OTUD4 TMPO UBR3 ZFR KDM7A MGA CNOT4 ZNF292 | 1.46e-05 | 1264 | 165 | 24 | ctd:D004113 |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 160 | 165 | 8 | 5275_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.25e-05 | 160 | 165 | 8 | 4404_UP | |
| Drug | Magnetite Nanoparticles | KIF21B CACNA1B STRN3 ATRX ZFYVE16 LEMD3 STXBP5 TNRC6B REST WDR26 MEF2A JMJD1C ZNF518A BLM CLMN STARD9 OTUD4 TMPO UBR3 ZFR KDM7A MGA CNOT4 ZNF292 | 2.60e-05 | 1310 | 165 | 24 | ctd:D058185 |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.93e-05 | 166 | 165 | 8 | 5324_UP | |
| Drug | In-G | 3.48e-05 | 170 | 165 | 8 | CID000446054 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.63e-05 | 171 | 165 | 8 | 6879_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 3.63e-05 | 171 | 165 | 8 | 5026_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.94e-05 | 173 | 165 | 8 | 2881_DN | |
| Drug | AC1L2FXT | 4.32e-05 | 10 | 165 | 3 | CID000071316 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.63e-05 | 177 | 165 | 8 | 4652_DN | |
| Drug | DMHPA | 5.22e-05 | 2 | 165 | 2 | CID000170229 | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.86e-05 | 183 | 165 | 8 | 1709_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.86e-05 | 183 | 165 | 8 | 3232_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.08e-05 | 188 | 165 | 8 | 4845_DN | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.35e-05 | 189 | 165 | 8 | 4401_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.35e-05 | 189 | 165 | 8 | 4304_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 7.35e-05 | 189 | 165 | 8 | 5084_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.63e-05 | 190 | 165 | 8 | 2619_DN | |
| Drug | AC1L2XIZ | 7.84e-05 | 12 | 165 | 3 | CID000104803 | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.91e-05 | 191 | 165 | 8 | 2227_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 8.21e-05 | 192 | 165 | 8 | 4274_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 8.21e-05 | 192 | 165 | 8 | 1076_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; MCF7; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 1703_UP | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 5109_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; HL60; HG-U133A | 9.14e-05 | 195 | 165 | 8 | 1979_DN | |
| Drug | BAS 012416453; Up 200; 38uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 6880_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 4208_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 7287_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 6930_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 1698_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 3065_DN | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 7061_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 4773_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 4282_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.02e-04 | 198 | 165 | 8 | 1070_DN | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 7216_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5885_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5501_DN | |
| Drug | Sulfaphenazole [526-08-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5507_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 5469_DN | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 4641_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 7009_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 1705_UP | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 2115_UP | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 1.09e-04 | 200 | 165 | 8 | 1953_DN | |
| Disease | Seizures | 3.36e-06 | 218 | 161 | 9 | C0036572 | |
| Disease | Intellectual Disability | TANC2 CACNA1B TRIO ZMYM2 WDR26 BPTF TPP1 MED12L MACF1 PUM1 FOXG1 ZNF292 | 6.87e-06 | 447 | 161 | 12 | C3714756 |
| Disease | alcohol consumption measurement | POU6F2 WAPL CTTNBP2 ZNF618 LINGO2 REST CHRM2 MBOAT2 FAM135B PHC2 HMG20A ALMS1 RBMS3 ARID2 ST6GALNAC5 TNRC6A KIF2A MGA EP300 CNOT4 | 1.53e-05 | 1242 | 161 | 20 | EFO_0007878 |
| Disease | age at menarche | ARMT1 ECPAS YWHAB ZNF518A HMG20A FAM83B DST ALMS1 RBMS3 TNRC6A RORB UNC79 UNC80 | 2.47e-05 | 594 | 161 | 13 | EFO_0004703 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.37e-05 | 364 | 161 | 10 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | diet measurement | CELF4 WAPL CTTNBP2 TRIO ZNF618 TNRC6B DGKG LINGO2 RALGAPA2 JMJD1C DST ARID2 TNRC6A UBR3 MBD5 CNOT4 MYO16 | 6.42e-05 | 1049 | 161 | 17 | EFO_0008111 |
| Disease | Neurodevelopmental Disorders | 1.60e-04 | 93 | 161 | 5 | C1535926 | |
| Disease | body weight | CACNA1B DSPP TNRC6B DGKG LINGO2 CEP192 HUWE1 YWHAB PHC2 BPTF USF3 RBMS3 TNRC6A TLN2 DMP1 PATJ MGA UNC79 | 1.91e-04 | 1261 | 161 | 18 | EFO_0004338 |
| Disease | alcohol dependence measurement | 2.34e-04 | 55 | 161 | 4 | EFO_0007835 | |
| Disease | feeling emotionally hurt measurement | 2.51e-04 | 56 | 161 | 4 | EFO_0009599 | |
| Disease | neuroimaging measurement | KIF21B STRN3 CELF4 CTTNBP2 MBP TNRC6B PLXND1 JMJD1C CRMP1 SEMA3A SBNO1 TNRC6A MACF1 TLN2 FOXG1 MYO16 | 2.61e-04 | 1069 | 161 | 16 | EFO_0004346 |
| Disease | Epidermolysis Bullosa Simplex | 2.93e-04 | 5 | 161 | 2 | C0079298 | |
| Disease | cognitive function measurement | TANC2 POU6F2 CELF4 DSPP ZNF618 SPPL3 LINGO2 CEP192 TEX14 JMJD1C FAM135B EDEM3 ALMS1 ST6GALNAC5 TNRC6A MED12L ZFR ARHGAP21 CNOT4 | 3.22e-04 | 1434 | 161 | 19 | EFO_0008354 |
| Disease | visceral adipose tissue measurement | 3.28e-04 | 481 | 161 | 10 | EFO_0004765 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.50e-04 | 61 | 161 | 4 | C1961102 | |
| Disease | body fat percentage | 3.67e-04 | 488 | 161 | 10 | EFO_0007800 | |
| Disease | waist-hip ratio | TNRC6B DGKG LINGO2 CEP192 PLXND1 CLOCK CHRM2 MEF2A JMJD1C PHC1 BPTF PPP2R3A MYO3B EPC1 TNRC6A PATJ ARHGAP21 | 4.04e-04 | 1226 | 161 | 17 | EFO_0004343 |
| Disease | macrophage colony-stimulating factor 1 receptor measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0020547 | |
| Disease | Microcephaly | 5.01e-04 | 67 | 161 | 4 | C0025958 | |
| Disease | Developmental regression | 6.10e-04 | 7 | 161 | 2 | C1836830 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 6.10e-04 | 7 | 161 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | R-warfarin measurement | 6.56e-04 | 265 | 161 | 7 | EFO_0803324 | |
| Disease | cancer (implicated_via_orthology) | 7.01e-04 | 268 | 161 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | grip strength measurement | 7.06e-04 | 350 | 161 | 8 | EFO_0006941 | |
| Disease | intellectual disability (implicated_via_orthology) | 7.68e-04 | 75 | 161 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 9.78e-04 | 80 | 161 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Abnormality of the face | 1.04e-03 | 9 | 161 | 2 | C4025871 | |
| Disease | Facial wrinkling | 1.08e-03 | 37 | 161 | 3 | HP_0009762 | |
| Disease | FEV/FEC ratio | CTTNBP2 DSPP STRBP EPB41L5 DGKG REST JMJD1C FAM83B MGAT5 DST RBMS3 EPC1 OTUD4 KDM7A MGA MYO16 | 1.16e-03 | 1228 | 161 | 16 | EFO_0004713 |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 1.29e-03 | 10 | 161 | 2 | EFO_1000650, HP_0000131 | |
| Disease | Cryptorchidism | 1.29e-03 | 10 | 161 | 2 | C0010417 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CTTNBP2 LINGO2 REST FAM135B PHC2 ZNF518A BPTF MGAT5 ALMS1 TNRC6A BICRAL UNC79 | 1.54e-03 | 801 | 161 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Neuroendocrine Tumors | 1.58e-03 | 11 | 161 | 2 | C0206754 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 1.58e-03 | 11 | 161 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 1.68e-03 | 43 | 161 | 3 | EFO_0007788, EFO_0008343 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.91e-03 | 45 | 161 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | Adenoid Cystic Carcinoma | 2.23e-03 | 100 | 161 | 4 | C0010606 | |
| Disease | hippocampal CA1 volume | 2.30e-03 | 48 | 161 | 3 | EFO_0009394 | |
| Disease | nephroblastoma (is_implicated_in) | 2.58e-03 | 14 | 161 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | colonic neoplasm, overall survival | 2.58e-03 | 14 | 161 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.59e-03 | 50 | 161 | 3 | EFO_0010732 | |
| Disease | Leukemia, Myelocytic, Acute | 2.65e-03 | 173 | 161 | 5 | C0023467 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 2.97e-03 | 15 | 161 | 2 | EFO_0004791, HP_0002140 | |
| Disease | infant head circumference | 2.97e-03 | 15 | 161 | 2 | EFO_0004577 | |
| Disease | estradiol measurement | 3.15e-03 | 110 | 161 | 4 | EFO_0004697 | |
| Disease | lung small cell carcinoma (is_marker_for) | 3.38e-03 | 16 | 161 | 2 | DOID:5409 (is_marker_for) | |
| Disease | focal segmental glomerulosclerosis | 3.38e-03 | 16 | 161 | 2 | EFO_0004236 | |
| Disease | T-Cell Lymphoma | 3.38e-03 | 16 | 161 | 2 | C0079772 | |
| Disease | Ischemic stroke, fibrinogen measurement | 3.40e-03 | 55 | 161 | 3 | EFO_0004623, HP_0002140 | |
| Disease | carotid artery intima media thickness | 3.40e-03 | 450 | 161 | 8 | EFO_0007117 | |
| Disease | Schizophrenia | CACNA1B MBP REST CLOCK CHRM2 CRMP1 SEMA3A SBNO1 TET1 KIF2A MYO16 TBP | 3.42e-03 | 883 | 161 | 12 | C0036341 |
| Disease | Drug habituation | 3.69e-03 | 115 | 161 | 4 | C0013170 | |
| Disease | Drug abuse | 3.69e-03 | 115 | 161 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.69e-03 | 115 | 161 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.69e-03 | 115 | 161 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.69e-03 | 115 | 161 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.69e-03 | 115 | 161 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.69e-03 | 115 | 161 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.69e-03 | 115 | 161 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.69e-03 | 115 | 161 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.81e-03 | 116 | 161 | 4 | C0740858 | |
| Disease | S-adenosylhomocysteine measurement | 3.81e-03 | 17 | 161 | 2 | EFO_0010531 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.81e-03 | 17 | 161 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | macula measurement | 3.87e-03 | 189 | 161 | 5 | EFO_0008375 | |
| Disease | open-angle glaucoma | 4.05e-03 | 191 | 161 | 5 | EFO_0004190 | |
| Disease | testosterone measurement | SLC17A2 NHSL2 HLA-H LINGO2 JMJD1C SEMA3A FBXO38 MGAT5 RBMS3 C18orf63 NCOA1 MACF1 RORB ARHGAP21 MYO16 | 4.31e-03 | 1275 | 161 | 15 | EFO_0004908 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 4.32e-03 | 194 | 161 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | atrial fibrillation | 4.39e-03 | 371 | 161 | 7 | EFO_0000275 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.76e-03 | 19 | 161 | 2 | EFO_0004630, HP_0002140 | |
| Disease | cleft lip | 4.80e-03 | 284 | 161 | 6 | EFO_0003959 | |
| Disease | metabolic syndrome | 4.91e-03 | 200 | 161 | 5 | EFO_0000195 | |
| Disease | maximal midexpiratory flow rate | 5.27e-03 | 20 | 161 | 2 | EFO_0004313 | |
| Disease | unipolar depression, memory performance, cognitive function measurement | 5.27e-03 | 20 | 161 | 2 | EFO_0003761, EFO_0004874, EFO_0008354 | |
| Disease | Alzheimer disease | 5.31e-03 | 485 | 161 | 8 | MONDO_0004975 | |
| Disease | optic disc size measurement | 5.45e-03 | 205 | 161 | 5 | EFO_0004832 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GESSSQNTNVLNSLE | 201 | Q9H993 | |
| SNNQQAAATQSPGDS | 1716 | Q09472 | |
| ANSNSSTNTSQNLAS | 611 | Q9H2F5 | |
| SGDNKQTTVSNSQQA | 136 | P31946 | |
| ANGLSSSQEAQLQQA | 456 | Q7Z695 | |
| SSGTGQSNTVQNILE | 566 | Q6P2P2 | |
| LSSANQNFNNSETLG | 236 | P35670 | |
| SSSGSNNNLSISNEE | 761 | P51816 | |
| IDNLNSSDSSVSSNN | 2206 | Q8TCU4 | |
| IQEASNAATQQFSGT | 1431 | Q68CP9 | |
| SIIDNAGATNRSNTN | 141 | Q9NZW4 | |
| MNNSTNSSNNSLALT | 1 | P08172 | |
| QNSSSGQAASSHEQA | 686 | P20930 | |
| SRNQGSSVSQDSDSQ | 1911 | P20930 | |
| NQNSSGSQVNSAGSL | 1951 | O75179 | |
| SNSQTNGLNFSLQQL | 1136 | Q9P1Z9 | |
| NSVSANLGDNTTNAT | 631 | Q12830 | |
| NLENSNSSSELNSSQ | 706 | Q12830 | |
| SSTSLSNGGAIQNQE | 1916 | Q00975 | |
| LSGNEQLKNNGNSTS | 226 | Q01804 | |
| SNNSSNNSSGEQLSK | 46 | Q6XE24 | |
| TSGQQQQIAVDTSNE | 411 | Q6XE24 | |
| QAASSNSAQGSDVSL | 346 | P01893 | |
| NKTRNSNNNNTAAAT | 61 | Q9Y2U8 | |
| SNNNNTAAATVAAAG | 66 | Q9Y2U8 | |
| NSDQNSRSSSQASGI | 581 | Q8IVT2 | |
| NQGLQERSTSQVASS | 4306 | Q8WXI7 | |
| ANINESTHISSSGQN | 911 | Q13127 | |
| QQNSQAGQRNSTSIE | 646 | O95819 | |
| TNNGLASNTFNSSSL | 281 | Q06828 | |
| NSNLTSGACQISNGS | 861 | Q6ZMT4 | |
| QSADLNNSSNSGMSL | 1366 | Q86YW9 | |
| AQTSADGSQAQNLES | 226 | Q9Y5V3 | |
| SSSAENTRQNGSNDS | 166 | P42166 | |
| NSLGQNSFSTTNNVC | 491 | Q6ZWT7 | |
| NSSGIISENQANNFV | 941 | Q8IWI9 | |
| NLVVNGTGTNSTNST | 106 | Q09328 | |
| NANNHGIQLSNSLSS | 1726 | Q9Y6X6 | |
| SQGQLLQSESSNAAE | 56 | Q9NP66 | |
| ILANNSLSSNGNVTE | 116 | P40933 | |
| TSLLNDQQNNTGTDT | 2381 | Q03001 | |
| NLLQQQGTSSISGTN | 231 | P12035 | |
| QSSVTNASSGNDHLN | 576 | Q15652 | |
| TEQSTIGTTNQGQAQ | 1691 | Q2LD37 | |
| DSQNQSGEQISSSSQ | 811 | Q9BZQ6 | |
| GSQESAVQNITSSND | 4556 | Q5CZC0 | |
| ESQSRQNSSSAQGSS | 191 | Q5VYK3 | |
| SVALNQTTNGHTESN | 621 | Q5T0W9 | |
| TQNSLGNNHSFSTAN | 346 | P55316 | |
| NSTASSNNAYNVNSS | 191 | Q9NXR8 | |
| QTLNSQGSSQAQETH | 1376 | Q9Y4D7 | |
| NVFSRLTSNQSQGSA | 1251 | O75037 | |
| SQEQSASASSGQPQA | 956 | Q5T1M5 | |
| LNDKNSNSGNSALNN | 351 | Q9ULH7 | |
| SNSGNSALNNATPNT | 356 | Q9ULH7 | |
| SGNVTVNQENNSLTS | 686 | O94854 | |
| ASSSSAFNQLTNNTA | 1651 | P35658 | |
| ENCQQSINSSNSGPS | 1411 | Q8NEV8 | |
| SNDTISNGTNANTFS | 521 | Q7L985 | |
| SSSAENTRQNGSNDS | 166 | P42167 | |
| LDSGPSSQNSSQNSD | 191 | Q96N21 | |
| SSQNSSQNSDLSRVS | 196 | Q96N21 | |
| KLNNSTGLQSSSVSQ | 311 | Q9ULI3 | |
| SSQNQSFNASSGLLS | 316 | Q9HCN3 | |
| LSQGSNLSINTNQNI | 386 | Q02078 | |
| SEQANTQDSGGSQLL | 246 | Q13316 | |
| SDSSQGQKAENTQNS | 776 | Q2PPJ7 | |
| EQDAQGASQDSSSNQ | 2276 | Q7Z6Z7 | |
| NSNFLNSHSQLTGQT | 536 | Q06190 | |
| GSTSTQTQESTNGQN | 311 | Q9UBG3 | |
| AAAATNSANQQTTPQ | 481 | Q14671 | |
| YGNNSLNSNSQSSSL | 646 | Q14671 | |
| LNSNSQSSSLFSQGS | 651 | Q14671 | |
| GIGVSSALVSNQNSN | 481 | Q6PIJ6 | |
| SQFPEQSSSAQQNGS | 121 | O00139 | |
| QSSSAQQNGSVSDIS | 126 | O00139 | |
| SNSEANSADTNIQNA | 96 | P49619 | |
| NQNTDKISGSGSNSD | 41 | P46100 | |
| SSILSTNNATFQNTG | 66 | P07333 | |
| ELSVHNNVSTQSNGS | 391 | Q9HCM4 | |
| SSTAQNINFSESIQN | 611 | P54132 | |
| LSNSSQISGSGQIQL | 201 | Q6AI39 | |
| SSSSNTRQIEINNNS | 1631 | Q8WZ74 | |
| GNDQDANGTSSSQLS | 311 | O43602 | |
| NQSLLQSQSSGDSSD | 206 | Q5VVM6 | |
| SEENTLNSQTNATSG | 266 | Q15398 | |
| ASSTATATLQLQQQQ | 586 | Q13495 | |
| SASSLQNASARNNLA | 156 | Q9Y4F3 | |
| ANQNNGTSSQDTAVT | 51 | P02686 | |
| QNKLAGNNSSSSSNS | 591 | Q9P267 | |
| INSSNSVTNRENNSA | 861 | Q8TEP8 | |
| NLTEVSSTGNADQQN | 441 | Q05932 | |
| SSTGNADQQNFTVTL | 446 | Q05932 | |
| GQAASQSQTSSVQSQ | 96 | Q5T749 | |
| SAADAINRNSTGQQS | 941 | Q49AJ0 | |
| QAQNRTSQGSSSFQT | 11 | Q92674 | |
| SANNNFTPSNNSSSE | 231 | Q99675 | |
| SSQASSNVEEGSNNP | 161 | Q13183 | |
| ANSNTNSNSSLITSQ | 831 | A3KN83 | |
| QNNLNVGSDTTSETS | 46 | B1AKI9 | |
| GNTQVQHTNLSSQSN | 416 | Q68DL7 | |
| QSNFSLSGAQIDDNN | 536 | Q14194 | |
| ISGSQQNNDLDASSE | 796 | Q8NG08 | |
| QSQQGLQENSSGQSF | 716 | P20273 | |
| STKSSGQSNNNSDTC | 46 | O14713 | |
| SNSIFNSSSNNLTRN | 246 | Q9H756 | |
| SQNQQTSNPTHSSED | 941 | Q9UPQ0 | |
| AQIVQTGANTNTTSS | 201 | P23511 | |
| NVDSNTQDLSGQTNE | 2046 | P56715 | |
| FTQGATKNTNQNSSA | 241 | Q9Y3Y4 | |
| SSQVDSGLQSNNHIN | 671 | Q13033 | |
| QVNSQLNCSVNGSSS | 281 | O94763 | |
| QQQGSSTVLHENTAS | 1346 | Q8IWB6 | |
| QDSVFNSIQSNTGRS | 91 | Q8NHS9 | |
| TPSATSQSNQVNENG | 401 | Q5HYW2 | |
| QQTTAHSSVLAGNSQ | 36 | Q6ZWJ8 | |
| ANVALNQGQASSQSS | 451 | Q15788 | |
| SQTSVGQAASQGNLL | 416 | P78424 | |
| SSNKQENSGSSSQLG | 116 | A0A1B0GUY1 | |
| SSSQQGNLHLSSQQG | 251 | A0A1B0GUY1 | |
| TNQSSLSDSNQAGIN | 6 | Q86VE3 | |
| LSDSNQAGINQPSTN | 11 | Q86VE3 | |
| INGTSTNSTEAENGN | 176 | P21815 | |
| IDAQLQSSNASVNQG | 351 | Q9HCD6 | |
| QQQQASATGSSQPAA | 46 | Q9BVH7 | |
| NETVSSNSSNNTGNS | 476 | Q96SI9 | |
| GSSLNSLNNLNNLSS | 236 | Q99697 | |
| ESNNVITFNGLANSS | 41 | Q14563 | |
| LNQESSFLSSQNGDS | 391 | Q96SB4 | |
| QNSQVFSSCQSLNSS | 291 | Q9P2P6 | |
| GGVDNNSSNNSNSSN | 106 | Q9NRC1 | |
| NSSNNSNSSNGDSDS | 111 | Q9NRC1 | |
| SNSSNGDSDSNRQSV | 116 | Q9NRC1 | |
| DGLTAGSSSASQQQQ | 11 | Q5T5C0 | |
| LNGSVVSTNTSNQTE | 21 | P30874 | |
| DNSLNSQSNTNTDRF | 191 | Q8N0Z3 | |
| NGQTTTLSNSHINSA | 971 | Q8NFU7 | |
| ATLANGQADNASLST | 6 | Q9BZC1 | |
| VEGTNNNSQSSSCNG | 496 | Q96JQ2 | |
| NNSQSSSCNGALEST | 501 | Q96JQ2 | |
| TSTQSQQNVLSGHSQ | 631 | O15516 | |
| SSQESNAQANVGSQE | 111 | Q16281 | |
| DSLSIGNGDNSQQIS | 281 | O95628 | |
| NLSANSNAQVLSGTE | 511 | Q9NR97 | |
| SNRQGSTSGSNVSAQ | 116 | Q8IXK0 | |
| QAQRNSANNTTTSGL | 441 | Q5T7W0 | |
| GNNFTTVDNKSTAQN | 881 | Q8N2C7 | |
| NLDNESQTTSSSNNE | 606 | Q8TAF3 | |
| LISNRTSQQSASNSD | 6 | Q96G30 | |
| ALLSVNTATNQGNSA | 11 | Q9H3R2 | |
| NTATNQGNSADAVTT | 16 | Q9H3R2 | |
| SSQSSNDLTGNVVAN | 1801 | Q13129 | |
| SARTTSQNSQGSQQS | 1621 | Q8NI35 | |
| AVQQSTSQQATQGTS | 101 | P20226 | |
| FNGNSTNNSIQTIDS | 56 | Q8TCT6 | |
| SAQQTNTAGSNVTTS | 116 | Q9UMX0 | |
| SEQGSTSQEQALSAQ | 666 | Q8NEM7 | |
| VNTTQQQGLSNASTE | 46 | O00624 | |
| SISNGLSNLNNETSG | 136 | Q92753 | |
| SGTNSVFSQLENNTN | 1281 | O60281 | |
| ETQANTSSNVSNDFQ | 2501 | O60281 | |
| QSNQATALAFLGSQS | 176 | Q9Y5U2 | |
| DNSQDSQSGTNNAEN | 496 | Q7Z5K2 | |
| AQASSGATNQSLNLS | 251 | P78364 | |
| NINSLTRISSAGNTQ | 416 | Q68DE3 | |
| NTFGALASLNQSISQ | 706 | Q68DE3 | |
| NSQTAANSQTTTANC | 736 | Q68DE3 | |
| AANNLSVSNSASSLQ | 1156 | Q6AHZ1 | |
| QNTNLGDVSNGLQSS | 221 | Q9UBW7 | |
| STVLQGQQQAASSAS | 441 | Q9NZI7 | |
| QNTSSSNSSTRGTQN | 366 | Q96KR1 | |
| SDNLGSLQNSGTAQV | 1021 | Q6ZT12 | |
| TSSSDNSVQLLNTNQ | 731 | Q86YA3 | |
| ATQTIAASQNAAVSN | 931 | Q9Y4G6 | |
| AASNNSNSLNVNNGV | 66 | Q9H7D7 | |
| ALSLQQDQQGSSSSA | 2821 | Q5T4S7 | |
| QDQQGSSSSALGLQS | 2826 | Q5T4S7 | |
| FQNVSKNASSAANAQ | 1926 | Q5T5U3 | |
| TTNACSTSGNSNLSQ | 261 | Q9UL49 | |
| SNNGTSTATSTNNNA | 71 | Q8NDV7 | |
| NSGSVQNNELPSSNT | 466 | Q8NDV7 | |
| SASEQSVQSTQSNGS | 2531 | O75962 | |
| AQQTEALASTGSQAQ | 286 | Q9BU19 | |
| TNQLSVSDINSQSVG | 631 | Q7Z3T8 | |
| SSENTTDNNSASNPG | 211 | Q9UPQ9 | |
| KSVQSSNSTTENNNG | 266 | Q9UPQ9 | |
| SGNNQSAGNTDSALI | 1701 | Q9P2D8 | |
| LTSQDVGSGTSNNSQ | 211 | O14773 | |
| TASQSAIQVNGNLSE | 126 | A6NMK8 | |
| AESNNGRTQTSSNSP | 1171 | Q8WXR4 | |
| STQATTQQAQLAAAA | 1906 | E9PAV3 |